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ABSTRACT 
Reliable detection of low template DNA (LTDNA) is dependent on reproducible 
allelic peaks and use of appropriately set thresholds.  Analyzing LTDNA at different 
thresholds than high template DNA samples is discouraged by some scientists [1].  Thus, 
enhancing LTDNA samples is preferred if thresholds set for high template DNA are 
maintained for LTDNA samples.  Post-amplification purification with the use of silica 
columns increases peak heights of single source LTDNA, while maintaining heterozygote 
balances of the sample before purification.  LTDNA samples are difficult to interpret due 
to stochastic effects: allelic dropout and heterozygote imbalance.  Interpretation of 
LTDNA mixtures is even more complex due to allelic sharing between contributors and 
allelic masking by artifacts.  To determine if post-amplification purification of DNA from 
two-person LTDNA mixtures can improve profile interpretation, variable concentrations 
and mixture ratios of saliva extracts were applied to Macherey-Nagel NucleoSpin® and 
Qiagen MinElute® columns.  
The peak heights and heterozygote balance of two-person LTDNA mixtures were 
compared before and after purification with each silica column.  Contributor proportion 
vi 
and heterozygote balance were not significantly affected by purification, and the peak 
heights of samples improved with use of either silica column.  However, peak heights 
were higher in samples purified with Qiagen MinElute® columns.  Given the higher peak 
heights, fewer dropouts occurred in samples purified with Qiagen MinElute® columns, 
but the occurrence of locus dropout reduced after purification with either column.  
The performance of each silica column was characterized by comparing fold 
increase and their individual effect on the primer front.  The fold increase of samples 
purified with Qiagen MinElute® columns was higher than samples purified with 
Macherey-Nagel NucleoSpin® columns, but replicate purifications of Macherey-Nagel 
NucleoSpin® columns were more precise than replicate purifications of Qiagen 
MinElute® columns.  Samples purified with Macherey-Nagel NucleoSpin® columns 
removed more primers than samples purified with Qiagen MinElute® columns.   
Post-amplification purification with silica columns is a useful investigative tool 
for LTDNA, especially for LTDNA mixtures.  Both silica columns increased peak height, 
maintained contributor proportion, maintained heterozygote balance, and reduced primer 
front, but the degree of fold increase and reduction in primer front must be considered to 
facilitate the decision of which silica column to use for post-amplification purification of 
LTDNA.  Due to its precision, Macherey-Nagel NucleoSpin® columns are ideal for 
LTDNA mixture samples while Qiagen MinElute® columns are ideal for single source 
LTDNA due to its ability to elevate peak heights. 
vii 
TABLE OF CONTENTS 
 Page 
Title Page i 
Reader’s Approval Page iii 
Acknowledgments iv 
Abstract v 
Table of Contents vii 
List of Tables  x 
List of Figures  xii 
List of Abbreviations  xvi 
1. Introduction 1 
1.1 DNA STR profiling 1 
1.2 Low template DNA  1 
1.2.1 LTDNA interpretation issues 2 
1.2.2 Reproducible allelic peaks of LTDNA samples 
1.2.3 Reliable allelic peak detection of LTDNA samples 
1.2.4 Enhancement of LTDNA samples 
1.2.4.1 Post-amplification purification of LTDNA samples 
2. Materials and Methods 
4 
6 
7 
9 
13 
2.1 DNA extraction 
2.2 DNA quantification 
2.2.1 QPCR 
13 
14 
14 
viii 
2.2.2 Spectrophotometry 
2.3 Amplification 
2.4 Post-amplification purification 
2.4.1 Post-amplification purification with Qiagen MinElute® columns 
2.4.2 Post-amplification purification with Macherey-Nagel NucleoSpin® 
columns 
2.5 Capillary electrophoresis 
2.6 Data analysis 
2.7 Characterization of single source saliva extracts 
2.8 Two-person LTDNA mixture creation 
3. Results 
15 
15 
16 
16 
 
17 
18 
19 
20 
21 
26 
3.1 Characterization of single source saliva extracts 
3.1.1 Peak height 
3.1.2 Heterozygote balance 
3.1.3 Allelic and locus dropout 
3.2 Two-person LTDNA mixture creation 
3.2.1 Two-person LTDNA mixture with two fresh saliva samples: BD 
mixture 
3.2.1.1 Contributor proportion & heterozygote balance 
3.2.1.2 Allelic and locus dropout 
3.2.1.3 Fold increase 
3.2.2 Two-person LTDNA mixtures with two frozen saliva samples: EG 
26 
26 
28 
30 
32 
 
32 
32 
35 
36 
 
ix 
& FG mixtures 
3.2.2.1 Contributor proportion & heterozygote balance  
3.2.2.2 Allelic and locus dropout 
3.2.2.3 Allelic fold increase 
3.2.3 Two-person LTDNA mixtures with one frozen saliva sample and 
one fresh saliva sample: GD & FC mixtures 
3.2.3.1 Contributor proportion & heterozygote balance 
3.2.3.2 Allelic and locus dropout 
3.2.3.3 Allelic fold increase 
3.2.3.4 Background noise of CE 
3.3 Comparison of post-amplification purification silica columns 
3.3.1 Fold increase and replicate purifications 
3.3.2 Primer front 
4. Discussion  
39 
40 
44 
50 
 
53 
54 
58 
60 
64 
65 
68 
69 
72 
5. Conclusions 76 
6. Future steps 77 
Appendix A:  Quantitative Data 78 
List of Journal Abbreviations 
Bibliography 
Curriculum Vitae 
79 
80 
85 
 
x 
LIST OF TABLES 
 Page 
Table 1.  Capillary electrophoresis run conditions. 19 
Table 2.  Number of loci in all possible heterozygote two-person 
mixture combinations without shared alleles. 
21 
Table 3.  Number of distinguishable loci in the 2-person mixture 
combinations created. 
22 
Table 4. Creating dilution stocks of contributors F and C at 0.25ng/μl, 
0.1ng/μl, 0.05ng/μl and 0.01ng/μl.   
22 
Table 5.  Amplification setup of 1:1, 4:1, and 9:1 FC mixture at 0.5ng, 
0.25ng, and 0.125ng target masses.   
23 
Table 6. Creating 1:1, 4:1, and 9:1 GD mixture dilution stocks at 
0.5ng/μl and 0.05ngμl. 
23 
Table 7. Creating 1:1 and 9:1 BD, EG, and FG mixture dilution stocks 
at 0.5ng/μl and 0.05ng/μl. 
24 
Table 8. Amplification setup of 1:1, 4:1 and 9:1 mixture samples 
targeted at 0.5ng, 0.25ng and 0.125ng. 
Table 9. Target mass of contributors in two-person mixtures at 0.5ng, 
0.25ng, and 0.125ng of 1:1, 4:1, and 9:1 ratios. 
24 
 
24 
Table 10. Average total fold increase across the profile of 0.25ng single 
source samples purified with Macherey-Nagel NucleoSpin® amd 
Qiagen MinElute® columns.   
28 
 
xi 
Table 11.  Average allelic fold increase of purifications at 0.25ng and 
0.125ng of 1:1 and 9:1 BD mixtures.   
 
38 
Table 12.  Allelic and locus dropout of 1:1 and 9:1 EG mixtures at 
0.25ng and 0.125ng targets before and after purification from 8 
discriminating loci. 
 
49 
Table 13.  Average allelic fold increase of purifications at 0.25ng and 
0.125ng of 1:1 and 9:1 EG mixtures.   
 
52 
Table 14. Average allelic fold increase of 0.5ng, 0.25ng and 0.125ng of 
1:1, 4:1 and 9:1 GD mixtures.  
Table 15. Average allelic fold increase of 0.5ng, 0.25ng, 0.125ng of 
1:1, 4:1, and 9:1 FC mixtures. 
Table 16.  Average total fold increase of two-person mixture samples 
purified with  Macherey-Nagel NucleoSpin® and Qiagen MinElute® 
columns.    
 
63 
 
64 
 
68 
 
  
  
  
  
  
  
  
xii 
LIST OF FIGURES 
 Page 
Figure 1.  Schematic of methods used to create two-person LTDNA 
mixture.   
25 
Figure 2.  Mean peak height across profile of seven 0.25ng single 
source samples before and after post-amplification purification.   
 
27 
Figure 3.  Heterozygote balance across the profile of seven 0.25ng 
single source samples before and after post-amplification purification.   
 
29 
Figure 4. Allelic and locus dropout across the profile of seven 0.25ng 
single source samples before and after post-amplification purification. 
 
31 
Figure 5.  Mean proportion of contributor B and contributor D in 1:1 
and 9:1 BD mixtures of 0.25ng and 0.125 targets from 6 discriminating 
loci before and after post-amplification purification.   
 
 
33 
Figure 6.  Mean heterozygote balance of each contributor in 1:1 and 9:1 
BD mixtures of 0.25ng and 0.125 targets from 6 discriminating loci 
before and after post-amplification purification. 
 
 
34 
Figure 7.  Allelic dropout of 1:1 and 9:1 BD mixture at 0.25ng and 
0.125ng targets before and after post-amplification purification from 6 
discriminating loci.   
 
35 
Figure 8.  Mean allelic fold increase of 1:1 and 9:1 BD mixtures at 
0.25ng and 0.125 targets from 6 discriminating loci.   
 
37 
Figure 9.  Total fold increase of 7 discriminating loci from 1:1 AD 39 
 
xiii 
mixture at 0.5ng target and single source samples A and D at 0.25ng 
targets.   
 
Figure 10.  Mean proportion of contributor E and contributor G in 1:1 
and 9:1 EG mixtures of 0.25ng and 0.125 targets from 8 discriminating 
loci before and after post-amplification purification.   
Figure 11.  Mean proportion of contributor F and contributor G in 1:1 
mixtures of 0.25ng targets from 6 discriminating loci before and after 
post-amplification purification. 
Figure 12.  Mean heterozygote balance of each contributor in 1:1 and 
9:1 EG mixtures of 0.25ng and 0.125 targets from 8 discriminating loci 
before and after post-amplification purification.   
Figure 13.  Mean heterozygote balance of each contributor in 1:1 FG 
mixture at 0.25ng target from 6 discriminating loci before and after 
post-amplification purification. 
Figure 14.  Allelic dropout of 1:1 and 9:1 EG mixture at 0.25ng and 
0.125ng targets before and after post-amplification purification from 8 
discriminating loci. 
 
 
41 
 
 
42 
 
 
43 
 
 
44 
 
45 
Figure 15.  Allelic dropout of EG mixture of each contributor before 
and after post-amplification purification from 8 discriminating loci. 
Figure 16.  Mean allelic fold increase of 1:1 and 9:1 EG mixtures at 
0.25ng and 0.125 targets from 8 discriminating loci. 
Figure 17.  Mean allelic fold increase of 1:1 FG mixture at 0.25ng target 
 
48 
 
51 
 
xiv 
from 6 discriminating loci. 
Figure 18.  Mean proportion of contributor G and contributor D in 1:1, 
4:1 and 9:1 GD mixtures of 0.5ng, 0.25ng and 0.125 targets from 10 
discriminating loci before and after post-amplification purification.   
Figure 19.  Mean proportion of contributor F and contributor C in 1:1, 
4:1 and 9:1 FC mixtures of 0.5ng, 0.25ng and 0.125 targets from 6 
discriminating loci before and after post-amplification purification. 
Figure 20.  Mean heterozygote balance of each contributor in 1:1, 4:1 
and 9:1 GD mixtures of 0.5ng, 0.25ng and 0.125 targets from 10 
discriminating loci before and after post-amplification purification. 
Figure 21.  Mean heterozygote balance of each contributor in 1:1, 4:1 
and 9:1 FC mixtures of 0.5ng, 0.25ng and 0.125 targets from 6 
discriminating loci before and after post-amplification purification.   
Figure 22.  Allelic dropout of 1:1, 4:1 and 9:1 GD mixtures at 0.5ng, 
0.25ng and 0.125ng targets before and after post-amplification 
purification from 10 discriminating loci.   
Figure 23.  Allelic dropout of 1:1, 4:1 and 9:1 FC mixture at 0.5, 0.25ng 
and 0.125ng targets before and after post-amplification purification 
from 6 discriminating loci.   
Figure 24.  Mean allelic fold increase of 1:1, 4:1 and 9:1 GD mixtures 
at 0.5ng, 0.25ng and 0.125ng targets from 10 discriminating loci. 
Figure 25.  Mean allelic fold increase of 1:1, 4:1 and 9:1 FC mixtures at 
53 
 
 
55 
 
 
56 
 
 
57 
 
 
58 
 
 
59 
 
 
60 
 
61 
 
xv 
0.5ng, 0.25ng and 0.125ng targets from 6 discriminating loci.   
Figure 26.  Electropherogram of 0.125ng of 4:1 GD mixture before and 
after purification using the blue dye loci.     
Figure 27.  Average total fold increase of all mixture samples analyzed 
of 1:1 mixture at 0.25ng.   
Figure 28.  Mean allelic fold increase of purification repeats in 0.5ng, 
0.25ng GD mixtures from 10 discriminating loci. 
Figure 29.  Electropherogram raw data of 9:1 GD mixture at 0.125ng 
before and after post-amplification purification.   
62 
 
65 
 
67 
 
69 
 
71 
 
xvi 
LIST OF ABBREVIATIONS 
ABI 
C 
CE 
Ct 
DI 
DNA 
FI 
Applied Biosystems® 
Celsius 
Capillary electrophoresis 
Cycle threshold 
Deionized water 
Deoxyribonucleic acid 
Fold increase 
IPC Internal PCR control 
ISFG International Society for Forensic Genetics 
kV Kilovolts 
LCN  Low copy number 
LTDNA Low template DNA 
μl Microliter 
mL Mililiter 
ng Nanograms 
nm Nanometers 
qPCR Quantitative PCR 
PCR Polymerase chain reaction 
Pg Picograms 
pH Power of hydrogen 
RFU Relative fluorescent unit 
xvii 
RPM Revolutions per minute 
STR 
TE 
Short tandem repeat 
Tris-Ethylenediaminetetraacetic acid buffer 
1 
1. INTRODUCTION 
1.1 DNA STR profiling 
Biological evidence can determine who was present at a crime scene by 
Deoxyribonucleic Acid (DNA) profiling techniques discovered by Dr. Alex Jeffreys [2], 
[3].  The hypervariable regions that are targeted in this technique are heritable and 
somatically stable, making it a valuable tool to analyze forensic samples[4], [5].  DNA 
profiles have been generated from bloodstains, semen stains, hair roots and fingerprints.  
With the advent of the polymerase chain reaction (PCR), a method discovered by Dr. 
Kary Mullis, the sensitivity of DNA profiling was elevated to detect 500 picogams (pg) 
of DNA with gel electrophoresis, but with capillary electrophoresis 80 zeptomole was 
detected [6]–[8].  The amount of DNA in touched items is not as copious as items 
saturated with biological fluids.  Short tandem repeat (STR) profiles from samples with 
low quantities of DNA must be approached with caution as these samples have low peak 
heights.  The low peak heights make it challenging to interpret due to stochastic effects 
and detection thresholds. 
 
1.2 Low template DNA  
Low copy number (LCN) and low-template DNA (LTDNA) are terms that have 
been used interchangeably to refer to samples with low amounts of DNA. LCN is 
distinguished by its mass, less than 100pg of DNA (less than 17 diploid cells), and falls 
below the stochastic threshold [9]–[13].  LTDNA is used to describe profiles where 
allelic dropout is possible; this includes samples with a low DNA mass [14].  From this 
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point forward, LTDNA samples will be used to identify samples with a low DNA 
template mass.  A study comparing LTDNA samples, 12pg and 25pg amplified at 34 
cycles, to a high template DNA sample, 1ng amplified at 28 cycles, found a 10% chance 
of allelic dropout per locus in LTDNA samples while no allelic dropout was observed in 
the 1ng DNA sample [12].  The dropout rate of an allele increases as the peak area of the 
corresponding heterozygote allele decreases [11].  Peak area is a direct measure of the 
amount of template in a sample, thus dropout rates increase as the DNA template mass 
decreases.  Similarly, as DNA template mass decreases the difference in peak area of 
heterozygote alleles, heterozygote imbalance, increases [11].  The discrepant patterns 
observed in LTDNA samples illustrate the difficulty analysts have in interpreting 
profiles.  
 
1.2.1 LTDNA interpretation issues  
DNA profile interpretation is based on the use of analytical and stochastic 
thresholds which affect the interpretation of data [15].  The two threshold approach is 
useful when characterizing stochastic effects: dropout and heterozygote imbalance [16].  
Given the limited quantity of DNA template in LTDNA, dropout occurs when peak 
heights of alleles do not exceed the analytical threshold.  Under these conditions, the 
genetic information of loci or alleles that dropped out is lost and the information is not 
available for comparison to a reference sample.  Dropout can affect genotype designation 
in extreme heterozygote imbalance conditions.  Drastic differences in the peak heights of 
heterozygote alleles can lead to the misidentification of heterozygote contributors as 
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homozygous contributors.  This effect is known as extreme dropout, when one allele is 
above the stochastic threshold while the other allele is below the analytical threshold 
[17].  Under these conditions, individuals can be falsely excluded when heterozygote 
contributors are not considered as possible contributors of a sample.  The interpretation of 
LTDNA profiles is difficult due to dropout and heterozygote imbalance, and it is further 
complicated with the drop-in of non-allelic peaks: stutter.   
Stutter in high template DNA profiles is characterized by the ratio of the stutter 
peak to the allelic peak which is generally less than 15% [18].  Meanwhile, the stutter 
ratio observed in LTDNA profiles can range from 15% to 25% [19].  The wide range of 
stutter ratios observed in LTDNA profiles makes it difficult to confidently distinguish 
stutter peaks from allelic peaks.  Unlike stutter in high template DNA profiles, stutter in 
LTDNA profiles can occur when the parent allele has dropped out [10], [11].  This effect 
is problematic as the stutter peak can be mischaracterized as an allele.  Allele designation 
of the stutter peak can lead to false inclusions or exclusions of individuals.  Stochastic 
effects are present in all DNA profiles, but their effect on LTDNA profiles is 
exacerbated. 
Dropout, heterozygote balance, and stutter in LTDNA profiles are more variable 
than high template DNA profiles.  Stutter peaks can be mistaken for allelic peaks and true 
heterozygote contributors can be mistaken for homozygous contributors. These effects 
raise concerns about the reliability of peaks in LTDNA profiles.  However, attempts to 
reproduce peaks have reduced these concerns and elevated confidence in the reliability of 
the peaks observed.   
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1.2.2 Reproducible allelic peaks of LTDNA samples 
Virtual profiles are created to improve the reproducibility and reliability of peaks 
from LTDNA samples [14].  Virtual profiles are profiles that have been artificially 
constructed by reporting alleles from multiple amplifications that satisfy a preset of 
guidelines [14].  Taberlet et al. recommend subjecting LTDNA to seven amplifications to 
ensure a 99% confidence that a heterozygote or homozygous contributor is accurately 
identified [20].  The mathematical model in this paper illustrated the danger of a one tube 
approach due to the unknown quantity of extracted DNA which can be inadequate for 
genotyping; meanwhile the value of a multiple tube approach was highlighted due to its 
ability to sequentially monitor three potential sources of errors: stochastic sampling 
(allelic dropout, stutter), false alleles (drop-in), and sporadic contamination [20].  The 
benefit of multiple amplifications is clear, but subjecting an already limited sample to 
seven amplifications is excessive due restricted sample size and risk of dropout.  Gill et 
al. illustrated the robust capability of the “duplication guideline”, duplicate independent 
amplifications of LTDNA samples, by comparing the consensus approach of duplicate 
samples to a Bayesian statistical model that calculated the likelihood ratio; if there was 
less than 30% sporadic contamination per locus, duplicate samples were reasonable and 
conservative [11].  Sporadic contamination is an issue if composite profiles are generated, 
but are not an issue for consensus profiles.  Consensus and composite profiles are 
examples of virtual profiles [14].   
A consensus profile, also known as a ‘biological model’, is obtained from two or 
more amplification samples where only duplicated alleles are reported [1].  Composite 
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profiles combine alleles reported in independent amplifications of the same extract 
regardless of the number of times the allele appears in the replicate [14].  Bright et al 
investigated the behavior of composite profiles with single source samples without 
dropout and single source samples with dropout.  When the dropout rate of a sample was 
low, composite profiles were appropriate; when dropout did not occur, the composite 
method was equivalent to a Bayesian statistical model.  As illustrated earlier, LTDNA 
has relatively higher dropout rates than high template DNA samples.  Thus, applying the 
composite method to LTDNA would be inappropriate.  Similarly, if dropout rates are low 
the composite method is not useful due to repeat detection of alleles which can be 
identified through the consensus approach.  
Benschop et al. compared the composite approach, “pool profile” method, to a 
modified consensus approach, “n/2” method, that reports alleles detected in at least half 
of the replicate amplifications; each method detected alleles that were not detected by the 
other method [21].  This study confirmed the conservative method of the consensus 
approach over the composite approach, but the combination of both methods led to a 
higher percentage of detected alleles than if each method was applied separately.  Virtual 
profiles alleviate uncertainty of allelic peaks in LTDNA profiles.  However, some authors 
argue that stochastic effects like drop-out and drop-in are not taken into consideration in 
these profiles [22].  Arguably, stochastic effects are indirectly considered since the 
method assumes that true allelic peaks are reproducible and will appear in multiple 
amplifications while stochastic effects are not.   
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1.2.3 Reliable allelic peak detection of LTDNA samples 
Peak detection is based on thresholds set by a laboratory.  Arbitrarily chosen 
analytical thresholds lead to higher incidences of dropout and produce larger error rates: 
detection of non-allelic peaks if the threshold is set too low and not detecting true allelic 
peaks if the threshold is set too high [15].  These outcomes are not ideal in a forensic 
setting as individuals can be falsely included or excluded as possible contributors.  Given 
the characteristics of LTDNA compared to high template DNA, analytical thresholds set 
for high template DNA profiles are not appropriate for LTDNA profiles.  Therefore, 
thresholds specific to LTDNA samples are defined.  LTDNA thresholds are determined 
by observing dropout rates of high template DNA samples, taking pre-defined risks into 
consideration:  dropout and heterozygote imbalance, and applying these values to 
LTDNA profiles to determine an appropriate analytical threshold [15], [17], [23].  The 
technique of defining a LTDNA threshold is not implemented in forensic laboratories as 
many scientists share the idea that the ‘cut-off’ point between high template DNA and 
LTDNA samples is gradual and cannot be defined or evaluated.  Therefore, a single 
analytical threshold approach to deal with stochastic effects that are observed in all DNA 
profiling methods is more beneficial than analyzing samples with different thresholds [1], 
[24].  However, the low DNA mass in LTDNA samples produce low peak heights that 
make it difficult to surpass the threshold values set for high template DNA samples.  To 
improve the detection of LTDNA profiles, some authors enhance LTDNA samples to 
exceed the analytical threshold [13].    
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1.2.4 Enhancement of LTDNA samples 
Increasing PCR cycle number, increasing PCR annealing/extension time, 
increasing injection time and purifying a sample after amplification are common 
enhancement techniques.  Adjustments in cycle number and annealing time improve 
detection by promoting amplification of the low amount of STR targets.  Elevated cycle 
numbers presume an increase in the amount of sample product since PCR exponentially 
amplifies targeted nucleic acid sequences in vitro.  However, increasing the PCR cycle 
number to 34 cycles in samples of less than 100pg was shown to reduce the profile 
quality by causing elevated heterozygote imbalance, stutter and contamination [11], [19].  
There is no advantage of raising the cycle number above 34 cycles due to the degradation 
of Taq polymerase [11].  In an effort to ameliorate this issue, samples that failed to 
generate a complete profile after 28 cycles were subject to another 6 cycles after 2.5U of 
DNA polymerase was added [9].  This approach was as effective as samples that 
underwent 34 cycles by elevating peak heights, but it also increased the risk of 
contamination, dropout and heightened stutter peaks [9].   
The consequences of elevated PCR cycles are not desirable, thus other aspects of 
PCR were adjusted to enhance LTDNA: increasing annealing time.  After DNA is 
denatured, primers anneal to each template strand and extend to form products.  
Increasing the annealing time ensures that primers have enough time to anneal to the 
template strand which, in theory, would reduce the dropout rate and heterozygote 
imbalance.  Increasing the annealing time from 1 minute to 20 minutes reduced dropout 
rates, generated higher peak heights, and gave full profiles from a 36pg sample [25].   
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Applying this method to unequal mixture samples did not cause over-amplification or 
over-loading of the major contributor(s), and the minor contributors were detected, but 
the total amplification time was 10 hours.  An enhancement technique that generates 
quality profiles from LTDNA samples in a reasonable amount of time is preferred in a 
forensic setting and can be accomplished by adjusting components in capillary 
electrophoresis. 
Capillary electrophoresis (CE) is used to separate and resolve multiplex amplified 
products, but it can also be used to enhance the sensitivity of STR typing of LTDNA 
samples.  The selective capacity of a CE is defined by its electrokinetic injection.  
Electrokinetic injection, a sample loading mechanism, involves applying a voltage to 
amplified DNA fragments; the voltage moves the negatively charged molecules from the 
sample well into the capillary [26].  DNA is negatively charged due to its phosphate 
backbone, so applying a positive voltage draws DNA along with other components in 
solution which also have a negative charge into the capillary.  Increasing the 
electrokinetic injection of a sample presumes an increase in product in the capillary, since 
elevated injection time at a constant voltage allows more product to enter the capillary.  
Increasing the CE voltage from 3kV to 9kV and injection time from 10 seconds to 15 
seconds led to a 6 fold increase in peak height of 16pg DNA samples, but had little effect 
in reducing locus dropout and drop-in, in the form of dye-blobs, a PCR chemistry artifact 
[27].  Increasing injection time is a valuable technique for LTDNA, but issues 
surrounding profile interpretation remain the same: dropout, heterozygote imbalance and 
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elevated stutter peaks.  The inconsequential improvement in profile quality is due to the 
selective limitation of the CE. 
The amount of DNA that is injected into a capillary is inversely proportional to 
the ionic strength of a solution; the presence of ions like chloride ion in a PCR mixture 
competes with amplified DNA products and reduces the amount of DNA injected since 
ions have a higher charge to mass ratio [28].  Reducing competition between ions and 
DNA causes an increase in the amount of DNA injected into the capillary which may 
improve profile quality.  An alternate enhancement method, post-amplification 
purification, attempts to alleviate allelic dropout as sample products are concentrated and 
purified from other components of a PCR kit. 
 
1.2.4.1 Post-amplification purification of LTDNA samples 
Smith and Ballantyne conducted a study to purify a sample using post-
amplification purification methods:  a filtration device, a silica gel membrane column, 
and an enzyme mediated hydrolysis [29].  No off ladder calls or artifacts were observed 
below 100 relative fluorescence units (RFU) with the silica gel membrane column; 
meanwhile, off ladder alleles were observed with the filtration device and low fluorescent 
signal intensities, peak heights, and non-allelic peaks were observed with the enzyme 
mediated hydrolysis [29].  The silica gel membrane generated profiles with the most 
relevant genetic information as allele peaks were detected and non-allelic peaks were not.  
Silica based columns are preferred over filtration devices due to faster sample processing 
time and concentration of samples [30].   
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Silica based membranes utilize the binding relationship between chaotropic 
agents and DNA [31].  The adsorption of DNA to silica is highly dependent on the salt 
concentration and the amount of free water molecules available to solvate DNA to silica 
surfaces; adsorption is driven by dehydration  and entropy [32].  Purification of nucleic 
acids after amplification exploits the binding relationship between DNA (the PCR 
products) and chaotropic salts to provide higher fluorescent allelic signals in LTDNA 
profiles.  Samples purified with a silica column after the standard 28 PCR cycle 
amplification generated full DNA profiles in samples as low as 20pg, when 25ul of 
purified product was added to the column, and 78pg, when 1.5μl of the purified product 
was added to the column; there was no relationship between signal fold increase and 
input quantity of DNA [29].  Post-amplification purification had similar effects to 
samples enhanced by elevated PCR cycles.  Similar peak heights and number of peaks 
per profile were observed in samples that were purified after 28 cycles of PCR and in 
samples that were not purified after 34 cycles of PCR, but purified samples did not 
exhibit off-scale data and had lower mean stutter proportion in 14 out of the 15 loci 
examined [33].   
Post-amplification purification improves the detection of LTDNA samples 
making it amenable for forensic application.  Blood and semen stained samples purified 
with NucleoSpin® columns produced higher DNA yields than non-purified samples [30].   
Post-amplification purification of post-coital swabs increased signal intensities of a Y-
STR profile; signal intensity was sufficient enough that a full profile was generated from 
a 6-day post coital swab and a partial profile was generated from a 7-day post coital swab 
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[34].  These results are significant since obtaining a full Y-STR profile from a post coital 
swab after 72 hours is challenging [35].   
Applying post-amplification purification with silica columns to LTDNA mixture 
samples can expand its application to complex forensic samples.  However, allele sharing 
and stochastic effects complicate the identification of a mixture and the number of 
contributors.  Mixture samples are characterized by observing the number of alleles 
present within each locus.  If more than two alleles are present in multiple loci or if peak 
height asymmetry is observed in multiple loci the sample contains a mixture [36].  The 
maximum allele count method is not always reliable as 70% of four-person mixture 
samples were misidentified as two or three person mixtures [37].  Allelic sharing between 
contributors and allele masking by stutter complicate analysis as not all of the genetic 
information in a mixture sample is detected [38], [39].   
Stochastic effects like dropout and stutter raise the risk of misinterpreting not only 
the number of contributors in a mixture, but the genotype inference of each contributor.   
Similar to single source LTDNA samples, LTDNA mixture samples are susceptible to the 
misidentification of a heterozygote contributor as a homozygous contributor.  However, 
stochastic effects in LTDNA mixture samples are more difficult to detect than single 
source LTDNA samples due to the unknown number of contributors, the unknown ratio 
of each contributor, the degree of allele sharing, and the masking of minor contributors 
by stutter peaks.  All of these factors must be considered in mixture interpretation.   
Post-amplification purification of LTDNA can improve interpretation of profiles. 
Analysis of peak height, heterozygote balances, and stutter ratios were observed on single 
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source LTDNA before and after post-amplification purification.  After post-amplification 
purification, with silica membrane columns, peak heights increased (which recovered the 
alleles lost before purification), heterozygote balances were maintained, and stutter ratios 
were not elevated [40].  These effects distinguish an inconclusive result from an inclusion 
or exclusion.  Applying this method to LTDNA mixture samples can be a valuable tool in 
casework analysis as a majority of forensic samples involve multiple contributors.   
Post-amplification purification of two-person LTDNA mixture samples were 
analyzed by comparing peak heights and stochastic effects: dropout and heterozygote 
imbalance of samples.  To determine the effect of post-amplification purification on 
LTDNA mixture samples peak heights, contributor proportions, and contributor 
heterozygote balances were observed before and after purification.  Two silica columns 
were used to purify samples thus the performance difference of each was compared by 
observing the primer front and fold increase.  Similarly, the effect replicate purifications 
had on the primer front and fold increase were observed to determine if this method was 
viable in a forensic setting.      
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2. MATERIALS AND METHODS 
2.1 DNA extraction 
Fresh saliva samples were obtained from the expectorant of four volunteers and 
collected into separate 1.5 milliliter (mL) Eppendorf® Safe-Lock microcentrifuge tubes 
(Eppendorf, Hamburg, Germany).  Three additional single source saliva samples were 
obtained from a freezer of anonymous biological samples stored in -20°C.  The frozen 
saliva samples were stored at -20°C from about 2 to 6 months prior to DNA extraction 
while the fresh saliva samples were collected and extracted on the same day.   
All seven saliva samples were extracted with the Qiagen QIAamp® DNA 
Investigator Kit (Qiagen, Foster City, CA) and processed per the manufacturer’s protocol 
for the isolation of total DNA from small volumes of saliva [41].  Fresh saliva samples 
were centrifuged at 5,000 revolutions per minute (RPM) for 10 seconds to separate food 
particles from saliva, while frozen saliva samples were thawed to room temperature prior 
to extraction.  A portion, 80 microliters (μl), of all saliva samples was transferred to a 
DNA-free 1.5mL Eppendorf® tube.  Per the manufacturer’s instructions the tissue lysis 
buffer, Buffer ATL, lysis buffer, Buffer AL, and proteinase K were added to a final 
volume of 230μl before the samples were incubated at 56°C for an hour.  The samples 
were put over a QiaAmp® MinElute® column and washed with 100μl of 96-100% 
ethanol and incubated at room temperature for 3 minutes to remove ethanol from the 
column.  Samples were eluted with 55μl of elution buffer, Buffer ATE.  A reagent blank 
underwent all steps in the extraction procedure alongside the saliva samples.  Subsequent 
extractions of frozen samples were done in duplicate and pooled. 
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2.2 DNA quantification 
All extracts were quantified with two quantification methods: quantitative 
polymerase chain reaction (qPCR) and spectrophotometry.   
 
2.2.1 QPCR 
 QPCR was performed using the Applied Biosystems (ABI) Quantifiler® Human 
DNA Quantification Kit (Life Technologies, Foster City, CA) with a protocol setup by 
Boston University’s Biomedical Forensic Sciences DNA laboratory course [42], [43].  
The plate was placed in a 7500 Real-Time Polymerase Chain Reaction (PCR) System 
(Life Technologies, Foster City, CA) and analyzed with Sequence Detection System 
(SDS) software version 1.2.3 (Life Technologies, Foster City, CA).  After each run, the 
human slope and y-intercept were recorded and applied to an excel template created by 
Dr. Catherine Grgicak.  These values along with results from the run calculated the 
template concentration of each extract and recorded this value in nanograms per 
microliter (ng/μl).  Controls were implemented in each run with a negative control, 
positive control, and internal PCR control.  The negative control consisted of only 
components from the master mix.  The positive control contained a DNA standard that 
was included in the Quantifiler® kits, it has a known concentration of 200ng/μl [42].  The 
internal PCR control (IPC) is included in the Quantifiler® kit to measure the presence of 
PCR inhibitors.  If the cycle threshold (Ct), number of PCR cycles needed to cross a 
threshold fell out of the 20-30 range PCR inhibition was considered. 
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2.2.2 Spectrophotometry 
 All extracts were quantified with a Thermo Scientific™ NanoDrop™ 2000 
Spectrometer (Thermo Scientific, Waltham, MA).  NanoDrop™ 2000 software was 
launched to detect and record quantification values using absorbance at 260 nanometers 
(nm) and 280nm.  A reagent blank was used to establish a baseline for the spectrometer 
by adding 1μl to the bottom pedestal.  After wiping the pedestal with a dry Kimwipe® 
(Kimberley-Clark, Irving, TX), another 1ul of the reagent blank was added to confirm a 
zero value.  The pedestal was wiped with a Kimwipe® before 1μl of each extract was 
quantified.  Quantification values obtained from qPCR and NanoDrop™ were recorded 
into an excel worksheet.  Average quantification values for each extract were obtained 
from duplicate measurements in each quantification method. 
 
2.3 Amplification 
 Samples were amplified with ABI AmpFlSTR® Identifiler® Plus PCR 
Amplification Kit (Life Technologies, Foster City, CA) and processed according to the 
manufacturer’s protocol [44].  Positive and negative controls were implemented in each 
amplification.  The positive control contained master mix and 10μl of 0.1ng/μl of 9947A, 
control DNA included in the Identifiler® Plus Kit.  The negative control contained 
master mix and 10ul of TE buffer.   
 Quantification values from qPCR were used to calculate the volume of extract 
needed to reach the target mass.  Depending on the extract’s quantification value, extracts 
were diluted with TE buffer if needed.  Extracts with quantification values that did not 
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require dilution were added directly to the master mix.  Any volume difference between 
the extract added and the total 10μl volume determined the amount of deionized water 
(DI) added.  Each reaction was performed in a total volume of 25μl.  The amplification 
plate was agitated and centrifuged to remove bubbles before it was placed in the ABI 
GeneAmp® PCR System 9700 thermal cycler (Life Technologies, Foster City, CA).  The 
“Identifiler® plus” program was utilized:  initial incubation step at 95° for 11 minutes, 28 
cycles of denaturation at 94°C for 20 seconds and annealing/extension at 59°C for 3 
minutes, final extension at 60°C for 10 minutes, and final hold at 4°C for infinite amount 
of time [44].  Amplifications were done in quadruplicate and pooled providing a final 
volume of 100μl of amplified product.  
 
2.4 Post-amplification purification 
 Post-amplification purification was conducted with silica columns from two 
different manufacturers: Qiagen MinElute® columns (Qiagen, Valencia, CA) and 
Macherey-Nagel NucleoSpin® columns (Macherey-Nagel, Düren, Germany).  
 
2.4.1 Post-amplification purification with Qiagen MinElute® columns 
 A portion, 10μl, of the pooled amplified mixture product was purified with 
Qiagen MinElute® PCR Purification Kit (Qiagen, Valencia, CA) and processed 
according to the manufacturer’s protocol using a microcentrifuge [45].  Prior to use, 1X 
PCR buffer was prepared by diluting GeneAmp® 10X PCR buffer (Life Technologies, 
Foster City, CA) with deionized water.  The 1X PCR buffer was added to 10μl of 
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amplified product to bring the volume equal to 20μl of a sample reaction mix.  The 
sample reaction mix was added to 100μl of binding buffer, PB buffer, for a total volume 
of 120μl with a 5:1 ratio of buffer to sample reaction mix [45].  PH (power of hydrogen) 
indicator was not used or added to the PB buffer.  A wash buffer, PE buffer, was applied 
to the column.  To have consistency with prior work in the laboratory two wash steps 
were utilized [40].  Samples were eluted in 10μl of elution buffer, EB buffer, and the 
volume was brought up to 10μl with TE buffer if a full 10μl was not recovered.  Purified 
samples were stored in 0.2mL Eppendorf® tubes at 4°C.  MinElute® purifications were 
done in triplicate for each sample.  A negative control was incorporated with each sample 
set by applying the reagent blank or negative amplification control to a column alongside 
other samples. All centrifugation steps were done at 13,000 RPM for 1 minute.  
 
2.4.2 Post-amplification purification with Macherey-Nagel NucleoSpin® columns  
 A portion, 10μl, of amplified mixture products were purified with Macherey-
Nagel NucleoSpin® Gel and PCR Clean-up Kit (Macherey-Nagel, Düren, Germany) and 
processed according to the manufacturer’s PCR clean-up protocol [46].  Prior to use, 1X 
PCR buffer was prepared. To have consistency with prior work in the laboratory, 10μl of 
1X PCR buffer was added to 10μl of amplified product and 40μl of DI to bring the 
volume equal to 60μl of a sample reaction mix.  The sample reaction mix was added to a 
binding buffer, NT1 Buffer, in a total volume of 180μl with a 2:1 ratio of buffer to PCR 
reaction mix and added to the column.  A wash buffer, NT2 buffer, was applied to the 
column twice as per manufacturer’s protocol.  Samples were eluted in 10μl of elution 
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buffer, NE buffer, and the volume was brought up to 10μl with TE buffer.  Purified 
mixture samples were stored in 0.2mL Eppendorf® tubes at -20°C.  NucleoSpin® 
purifications were done in triplicate for each sample.  A negative control was 
incorporated in each sample set by applying the reagent blank or negative amplification 
control to a column alongside other samples. 
 
2.5 Capillary Electrophoresis 
 Samples were prepared with a master mix of formamide, 8.7μl per reaction, and 
Liz 600, 0.3μl per reaction.  A portion, 9μl, of the master mix was added to each well of a 
MicroAmp® 96-well optical plate (Life Technologies, Foster City, CA).  The final 
reaction volume in each well was 10μl after 1μl of amplified product or allelic ladder was 
added.  Positive and negative controls were implemented in each run.  Positive controls 
consisted of the positive amplification control and allelic ladder.  Negative control 
consisted of the negative amplification control.  Blank samples, 10μl of master mix, were 
added to any partially used columns of the 96 well plate.  The plate was sealed with 
septa, vortexed, centrifuged for a minute at 3,000 RMP, denatured in a 9700 
thermocycler at 95°C for 3 minutes, and placed in a freezer at -20°C for 3 minutes.  The 
ABI 3130 Genetic Analyzer Data Collection Software version 3.0 (Life Technologies, 
Foster City, CA) was launched, a plate record was created, and the plate was placed in 
the autosampler of the 3130 Genetic Analyzer (Life Technologies, Foster City, CA) 
before the run was initiated.  Further specifics for electrophoresis are shown in Table 1. 
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Table. 1.  Capillary electrophoresis run conditions. All electrokinetic injections were done at 5 seconds, 
unless stated otherwise.  
Temperature 60° C 
Run Voltage 15000 kV 
Injection Voltage 3000 kV 
Polymer POP 4 
Capillary length 36 cm 
 
 
2.6 Data Analysis 
 A naming scheme was applied to distinguish purified samples from unpurified 
samples and to distinguish samples purified with MinElute® columns from samples 
purified with NucleoSpin® columns.  After each 3130 run, samples were analyzed with 
GeneMapper® ID Software version 3.2 (Life Technologies, Foster City, CA) with an 
analytical threshold of 30RFU.  If dropout occurred, peak heights of alleles were 
observed in GeneMapper® by placing the cursor at the crest of the peak and recording 
the y-value in Excel®.  Allelic designations and peak heights from GeneMapper® were 
used to find total peak height, heterozygote balance, contributor proportion, and fold 
increase (FI) using calculations (Equations 1 through 6) in Microsoft® Excel®.  
Statistical tests and display figures were generated using SAS® JMP® software. 
 
Total peak height (RFU) = ∑                                                    (1) 
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Contributor peak height (RFU) 
= ∑                                                                           (2) 
 
Heterozygote balance =
                                                    
                                                     
           (3) 
 
Contributor proportion = 
                                          
                                    
           (4) 
 
Allelic fold increase = 
                                                             
                                                                 
          (5) 
 
Total fold increase per locus 
 = 
                                                        
                                                         
               (6) 
 
2.7 Characterization of single source saliva extracts 
 The seven single source extracts extracted from fresh or frozen saliva samples 
were processed as single source samples to determine if storage condition prior to 
extraction affected peak height and heterozygote balance.  This study was conducted to 
ensure that mixtures created from these samples would provide expected mixture ratios.  
A dilution stock of 1ng/μl and 0.05ng/μl was created for each sample.  These stocks were 
amplified using 1ng and 0.25ng of target DNA.  A portion, 10μl, of amplified product for 
each sample was purified with MinElute® and NucleoSpin® columns.  Purified and 
unpurified amplified products were injected into a CE for 5 seconds.   
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2.8 Two person LTDNA mixture creation 
 DNA profiles of the seven single source saliva samples were recorded in an excel 
worksheet.  All two-person mixture combinations of the extracts were compared.  Shared 
alleles were observed in all mixture combinations.  Mixture combinations were ranked by 
the number of loci without shared alleles (Table 2).  The number of loci where 
contributors were distinguishable from each other was recorded.  These loci fell into one 
of three categories:  loci with 4 alleles, loci with 3 alleles and no shares, and loci with 2 
alleles and no shares.   
 
Table 2.  Number of loci in all possible heterozygote two-person mixture combinations without 
shared alleles. 
Number of loci without 
shared alleles 
Number of mixture 
combinations 
Mixture 
combination 
10 1 GD 
8 4 BE, EG, AG, FD 
7 5 CE, BG, EF, ED, AD 
6 5 CF, CG, CB, BD, FG 
5 4 CA, CD, BF, AF 
4 1 EA 
3 1 BA 
 
Contributors were assigned based on the number of heterozygote or homozygous 
loci contained within the discriminating loci of each mixture combination.  The input of 
contributor 1 increased while the input of contributor 2 decreased as the mixture ratio 
moved from 1:1 to 4:1 and to 9:1.  Single source contributors with more homozygous loci 
were designated as contributor 1 and single source contributors with more heterozygote 
loci were designated as contributor 2.  Once a mixture combination was chosen and 
contributors 1 and 2 were assigned, the mixture was created (Table 3). 
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Table 3. Number of distinguishable loci in the 2-person mixture combinations created. 
Mixture 
Combination 
Number of 
distinguishable loci 
Sample Storage of 
Contributors 
FC 6 Frozen, Fresh 
GD 10 Frozen, Fresh 
BD 6 Fresh, Fresh 
EG 8 Frozen, Frozen 
FG 6 Frozen, Frozen 
 
 
 Before creating the FC mixture, extracts from each contributor were quantified 
and diluted to create single source dilution stocks of 0.25ng/μl; the 0.1ng/μl, 0.05ng/μl, 
and 0.01ng/μl dilution stocks were made from the more concentrated dilution stocks of 
the same contributor (Table 4).  These single source dilution stocks were used in the 
amplification setup to create 0.5ng, 0.25ng and 0.125ng targets at 1:1, 4:1 and 9:1 
mixture ratios (Table 5).  Amplifications were done in duplicate which were pooled and 
stored in a 0.2mL Eppendorf® tube at 4°C.  Duplicate post-amplification purifications 
were conducted.  However, one purification contained 5μl of product while the other 
purification contained 10μl of product.  
 
Table 4. Creating dilution stocks of contributors F and C at 0.25ng/μl, 0.1ng/μl, 0.05ng/μl and 
0.01ng/μl.  The 0.1ng/μl dilution stocks were made from the corresponding 0.25ng/μl stock.  The 0.05ng/μl 
dilution stocks were made from the corresponding 0.1ng/μl stock.  The 0.01ng/μl dilution stocks were made 
from the corresponding 0.05ng/μl stock. 
 
 
 
 
 
Dilution Stock Concentration Contributor F (ul) TE (ul) Total (ul) Contributor C (ul) TE (ul) Total (ul)
0.25ng/ul 42 328 370 6.5 193.5 200
0.1ng/ul 320 480 800 80 120 200
0.05ng/ul 400 400 800 150 150 300
0.01ng/ul 60 240 300 60 240 300
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Table 5.  Amplification setup of 1:1, 4:1, and 9:1 FC mixture at 0.5ng, 0.25ng, and 0.125ng target 
masses.  The colored cells correspond to the dilution stock used for each contributor.  Purple refers to the 
0.25ng/μl stock.  Blue refers to the 0.1ng/μl stock.  Green refers to the 0.05ng/μl stock.  Orange refers to 
the 0.01ng/μl stock. 
  
 
 The GD, BD, EG, and FG mixtures were created in a different manner than the 
FC mixture to simplify the amplification setup.  Thus, DNA extracts of each contributor 
involved in the mixture was diluted to create a single source stock of 1ng/μl.  The 1:1, 
4:1, and 9:1 mixture dilution stocks at 0.5ng/μl were created from 1ng/μl single source 
stocks in a total volume of 25μl (Tables 6 & 7).  The amount of 1ng/μl extract added to 
create the 0.5ng/μl stock solution of the 1:1 and 9:1 EG mixture differed than the other 
mixtures since sample E had signs of degradation.  Thus, double the amount of 
contributor E was placed in the 0.5ng/μl stock solution of the 1:1 and 9:1 EG mixture.  
 
Table 6. Creating 1:1, 4:1, and 9:1 GD mixture dilution stocks at 0.5ng/μl and 0.05ngμl.  The colored 
cells refer to the different mixture dilution concentrations.  Yellow refers to the 0.5ng/μl stock and green 
refers to the 0.05ng/μl stock. 
 
Target mass Mixture Ratio Contributor F (ul) Contributor C (ul) TE (ul) Total (ul)
1:1 1 1 8 10
4:1 4 1 5 10
9:1 9 1 0 10
1:1 2.5 2.5 5 10
4:1 2 1 7 10
9:1 4.5 2.5 3 10
1:1 1.25 1.25 7.5 10
4:1 1 2.5 6.5 10
9:1 2.25 1.25 6.5 100.125ng
0.5ng
0.25ng
0.5ng/ul 0.05 ng/ul 0.5ng/ul 0.05 ng/ul 0.5ng/ul 0.05 ng/ul
Contributor G (ul) 5.75 9.25 10.5
Contributor D (ul) 5.75 2.375 1.175
TE (ul) 13.5 45 13.375 45 13.325 45
Total (ul) 25 50 25 50 25 50
5 5 5
1:1 Mixture Diliution Stock 4:1 Mixture Diliution Stock 9:1 Mixture Diliution Stock
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Table 7. Creating 1:1 and 9:1 BD, EG, and FG mixture dilution stocks at 0.5ng/μl and 0.05ng/μl.  The 
colored cells refer to the different mixture dilution concentrations.  Yellow refers to the 0.5ng/μl stock and 
green refers to the 0.05ng/μl stock.  Only 1:1 mixture dilution stocks at 0.5ng/μl and 0.05ng/μl were created 
for the FG mixture.   
 
 
The GD mixture samples were amplified at 0.5ng, 0.25ng, and 0.125ng using the 
0.5ng/μl and 0.05ng/μl mixture stocks of each ratio; the BD and EG mixture samples 
were amplified at 0.25ng and 0.125ng using the 0.05ng/μl mixture stocks of 1:1 and 9:1 
mixture ratios; the FG mixture samples were amplified at 0.25ng using the 0.05ng/μl 
mixture stock of the 1:1 mixture ratio (Tables 8 & 9).   
 
Table 8. Amplification setup of 1:1, 4:1 and 9:1 mixture samples targeted at 0.5ng, 0.25ng and 
0.125ng.  The colored cells refer to the different mixture dilution concentrations.  Yellow refers to the 
0.5ng/μl stock and green refers to the 0.05ng/μl stock.   
 
 
Table 9. Target mass of contributors in two-person mixtures at 0.5ng, 0.25ng and 0.125ng of 1:1, 4:1, 
and 9:1 ratios.  
 
 
0.5ng/ul 0.05ng/ul 0.5ng/ul 0.05ng/ul
Contributor 1 (ul) 5 9
Contributor 2 (ul) 5 1
TE (ul) 10 45 10 45
Total (ul) 20 50 20 50
1:1 Mixture Diliution Stock 9:1 Mixture Diliution Stock
5 5
Target Mass 0.5ng 0.25ng 0.125ng
Mixture (ul) 1 5 2.5
DI Water (ul) 9 5 7.5
Total (ul) 10 10 10
Contributor 1 (ng) Contributor 2 (ng) Contributor 1 (ng) Contributor 2 (ng) Contributor 1 (ng) Contributor 2 (ng)
1:1 0.25 0.25 0.125 0.125 0.0625 0.0625
4:1 0.4 0.1 0.2 0.05 0.1 0.025
9:1 0.45 0.05 0.225 0.025 0.1125 0.0125
0.5 ng 0.25 ng 0.125 ng
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Refer to Figure 1 for an overview of the method involved in creating two-person 
LTDNA mixture samples used for this study.  
 
Figure 1. Schematic of methods used to create two-person LTDNA mixture.  Blue highlighted boxes, 
text, and arrows refer to only single source saliva samples.  Maroon highlighted boxes, text and arrows 
refer to only mixture saliva samples.  Grey highlighted boxes refer to both single source and mixture saliva 
samples. 
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3. RESULTS 
3.1 Characterization of single source saliva extracts 
The single source saliva DNA samples were first characterized by peak height, 
heterozygote balance, and allelic/locus dropout.  These characterizations were compared 
before and after purification with both Macherey-Nagel NucleoSpin® and Qiagen 
MinElute® columns.  Based on qPCR data (see Table A in Appendix) 1ng and 0.25ng of 
DNA was amplified for each single source extract, but only 0.25ng samples were applied 
to post-amplification purification columns. Amplification and purification were not 
replicated. 
 
3.1.1 Peak Height 
The mean peak heights after purification were discrepant between storage 
conditions.  The mean peak heights of fresh saliva samples, A through D, were at least 2 
fold higher than the mean peak heights of frozen saliva samples, E through G, before 
purification when the same amount of DNA was amplified as measured by qPCR (Figure 
2).  A pairwise comparison for each sample pair using the Tukey-Kramer method in JMP 
was performed.  There was a significant difference in peak height between all pair 
combinations of one fresh and one frozen sample.  The peak heights of samples A, B, C, 
and D are significantly higher than the peak heights of samples E, F, and G.  
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Figure 2. Mean peak height of profiles from seven 0.25ng single source samples before and after post-
amplification purification.  Samples were purified with Macherey-Nagel NucleoSpin® and Qiagen 
MinElute® columns.  Samples A through D were extracts from fresh saliva while samples E through G 
were extracts from frozen saliva.  Purifications were not replicated.  Each error bar was constructed using a 
95% confidence interval of the mean.  Values above each bar represent the mean.  
 
 
Post-amplification purification of each sample with Macherey-Nagel 
NucleoSpin® or Qiagen MinElute® columns elevated peak heights compared to non-
purified samples (Figure 2).  The discrepancy between peak heights of sample storage 
conditions was still evident in purified samples with higher mean peak heights in samples 
A through D than samples E through G.  However, samples purified with MinElute® 
columns had a higher total fold increase than samples purified with NucleoSpin® 
columns (Table 10). 
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Table 10. Average total fold increase across the profile of 0.25ng single source samples purified with 
Macherey-Nagel NucleoSpin® amd Qiagen MinElute® columns.  Purifications were not replicated.  FI 
represents fold increase.  
 
 
Purification of frozen and fresh saliva samples increased peak height.  The fold 
increase of these samples was similar within each silica column.  Extracts from frozen 
samples can undergo post-amplification purification to improve allelic detection.  The 
fold increase of these samples can be further improved by applying them to Qiagen 
MinElute® columns. 
 
3.1.2 Heterozygote balance 
Heterozygote balance was affected by target mass and the storage condition of 
samples prior to extraction.  The mean heterozygote balances were lower in 0.25ng target 
samples than 1ng target samples and in frozen saliva samples than fresh saliva samples.  
The heterozygote balance from fresh samples ranged from 0.64 to 0.99, while the 
heterozygote balance from frozen samples ranged from 0.18 to 1 (Figure 3).  The range 
of heterozygote balance for frozen samples does not include outlier values in sample E 
since the condition of the sample led to allelic dropout before and after purification.  
 
Purification
Sample A B C D E F G
Average Total FI 4.62 3.95 4.28 5.45 5.44 3.38 5.59
Standard Deviation 0.28 0.44 0.32 0.30 0.68 0.39 0.39
Purifiation
Sample A B C D E F G
Average Total FI 7.45 5.40 7.14 5.87 7.64 6.18 5.39
Standard Deviation 0.48 0.45 0.70 0.25 0.65 0.40 0.55
Qiagen MinElute®
Macherey_Nagel NucleoSpin®
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Figure 3.  Heterozygote balance across the profile of seven 0.25ng single source samples before and 
after post-amplification purification.  Samples were purified with Macherey-Nagel NucleoSpin® and 
Qiagen MinElute® columns.  Samples A through D were extracts from fresh saliva while samples E 
through G were extracts from frozen saliva.  The whiskers of the box plot represent the minimum and 
maximum values.  The 75
th
 and 25
th
 quartile are represented in the top and bottom portion of the 
rectangular box and the median is represented by the bar within the box. Values below the box plots of 
each sample represent the mean. 
 
 
The higher range in heterozygote balance of frozen samples compared to fresh 
samples makes it difficult to interpret profiles.  According to the International Society for 
Forensic Genetics (ISFG) guidelines, the heterozygote balance of the same contributor 
should not be less than 60% [36].  Based on this standard, if the heterozygote balances of 
alleles from a frozen sample is less than 0.6, interpreting the number of contributors must 
be done with caution as more than one contributor may be present; the sample condition 
can affect the heterozygote balance.  
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Based on the average and range shown in figure 3, post-amplification purification 
does not affect the heterozygote balance of samples.  The heterozygote balance of each 
sample before purification did not vary from the heterozygote balance after purification 
with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns; the mean values 
across the samples before purification was 0.77 ± 0.15 and after purification was 0.78 ± 
0.15.  This observation is significant in a forensic setting since altering the heterozygote 
balance of a sample would further complicate the interpretation of a mixture as 
contributors are distinguished based on part by heterozygote balances. 
 
3.1.3 Allelic and locus dropout 
 Allelic and locus dropout were only observed in one frozen saliva sample: sample 
E.  From the 336 loci of seven 0.25ng single source samples before and after purification 
combined there were 8 instances of allelic dropout, all of which came from sample E 
(Figure 4).   
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Figure 4. Allelic and locus dropout across the profile of seven 0.25ng single source samples before 
and after post-amplification purification.  Samples were purified with Macherey-Nagel NucleoSpin® 
and Qiagen MinElute® columns.  Samples A through D were extracts from fresh saliva while samples E 
through G were extracts from frozen saliva. Each data point represents number of allelic dropout per locus 
(N= 336).  The blue triangles represent occurrence of locus dropout while the red circles indicate no locus 
dropout. 
 
 
Allelic and locus dropout were more prevalent before purification.  Before sample 
E was purified there were 6 instances of locus dropout, but after purification all alleles 
except for one were recovered.  The one allele that did not recover in the purified samples 
was the same allele involved in the outlier heterozygote balance of sample E seen in 
Figure 3.   
 Sample E shows indications of degradation.  Not only did sample E have a high 
dropout rate, but the electropherogram of sample E in the yellow dye exhibited 
decreasing peak height of alleles as the base pair length increased.  Sample E was 
considered as a degraded LTDNA sample. 
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3.2 Two-person LTDNA mixture creation 
 
 Two-person LTDNA mixtures were created with single source samples to include 
a mixture of two frozen saliva samples, two fresh saliva samples, or a frozen saliva 
sample and a fresh saliva sample.  The combinations analyzed are shown in Table 3.  
Each mixture combination was categorized by one of the three classifications.  The BD 
mixture included two fresh saliva samples; the EG and FG mixtures included two frozen 
saliva samples; the FC and GD mixtures included a fresh and frozen saliva sample. 
 
3.2.1 Two-person LTDNA mixture with two fresh saliva samples: BD Mixture 
Samples A through D were extracted from fresh saliva samples.  The proportion 
and heterozygote balance of each contributor in the BD mixture was analyzed and 
compared before and after post-amplification purification with Macherey-Nagel 
NucleoSpin® and Qiagen MinElute® columns.  To investigate the effect of purification, 
dropout and fold increase was observed.   
 
3.2.1.1 Contributor proportion & heterozygote balance 
Contributor proportions observed in the BD mixture coincide with expected 
ratios.  The mean proportion of contributor B observed was 0.85 in both 9:1 mixture 
targets and the mean proportion of contributor D was 0.15 in both 9:1 mixture targets 
(Figure 5).  Similarly, the proportions of each contributor in both 1:1 mixture targets were 
close to the expected 0.5 proportions.  
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Figure 5.  Mean proportion of contributor B and contributor D in 1:1 and 9:1 BD mixtures of 0.25ng 
and 0.125 targets from 6 discriminating loci before and after post-amplification purification.  
Samples were purified with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns in triplicate 
(N= 72 each).  Non-purified samples were not replicated (N= 24).  The error bars represent 95% confidence 
interval from the mean. N= number of data points included.  
 
 The proportion of each contributor in the mixture was not affected by purification 
since values were maintained after purification.  This finding supports the use of post-
amplification purification in a forensic setting as the integrity of the sample was 
maintained. 
Purification had no significant effect on the heterozygote balance (Figure 6).  The 
error bars of the non-purified samples are larger than the purified samples due to limited 
data in a single run of non-purified samples.  Thus, purification did not reduce or increase 
the range in heterozygote balance of either contributor. 
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Figure 6.  Mean heterozygote balance of each contributor in 1:1 and 9:1 BD mixtures of 0.25ng and 
0.125 targets from 6 discriminating loci before and after post-amplification purification.  Samples 
were purified with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns in triplicate (N= 72 
each).  Non-purified samples were not replicated (N= 24).  N= number of data points included.  The error 
bars represent 95% confidence interval from the mean.  
 
 
The preservation of contributor proportions and contributor heterozygote balance 
in BD mixture samples after purification supports its viability in a forensic setting.  
Current practice in mixture interpretation involves identifying the heterozygote balance 
of a contributor to determine the proportion of that contributor in a mixture.  Preserving 
the contributor proportion and heterozygote balance of a LTDNA mixture after 
purification ensures that this technique is still applicable to samples purified post-
amplification. 
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3.2.1.2 Allelic and locus dropout 
 Dropout was only observed in non-purified 0.125ng target of 9:1 BD mixture 
samples (Figure 7).  There were two instances of locus dropout and one instance of allelic 
dropout within this sample.  The loss of genetic information only affected contributor D, 
which was expected given its target mass of 0.0125ng.  However, the genetic information 
of contributor D was recovered in samples purified with Macherey-Nagel NucleoSpin® 
or Qiagen MinElute® columns.  Detecting full profiles of both contributors in purified 
0.125ng targets of 9:1 mixture illustrates the benefit of purifying low template DNA 
mixture samples after amplification. 
 
 
Figure 7.  Allelic dropout of 1:1 and 9:1 BD mixture at 0.25ng and 0.125ng targets before and after 
post-amplification purification from 6 discriminating loci.  Samples were purified with Macherey-Nagel 
NucleoSpin® and Qiagen MinElute® columns. Non-purified samples were not replicated.   Purifications 
were done in triplicate.  Each data point represents the number of alleles dropped out per discriminating 
locus.  The blue triangles represent occurrence of locus dropout while the red circles indicate no locus 
dropout.   
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3.2.1.3 Fold increase 
Allelic fold increase in RFU was equivalent across the loci, but allelic fold 
increase was higher in samples purified with Qiagen MinElute® columns than samples 
purified with Macherey-Nagel NucleoSpin® columns (Figure 8).  The overall mean fold 
increase across distinguishable alleles of all BD mixture samples purified with Qiagen 
MinElute® columns was 5.04 ± 0.86 while the overall mean fold increase across 
distinguishable alleles of BD mixture samples purified with Macherey-Nagel 
NucleoSpin® columns was 4.09 ± 0.60 (Table 11).  The fold increase of NucleoSpin® 
samples was more precise than MinElute® samples overall.  However, the allelic fold 
increase of MinElute® samples was more precise than NucleoSpin® samples in 0.125ng 
targets, while the allelic fold increase of NucleoSpin® samples was more precise than 
MinElute® samples in 0.25ng targets as indicated by the error bars in Figure 8 and the 
standard deviation of the means in Table 11. 
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Figure 8.  Mean allelic fold increase of 1:1 and 9:1 BD mixtures at 0.25ng and 0.125 targets from 6 
discriminating loci.  Figure A represents samples purified with Macherey-Nagel NucleoSpin® columns 
(N= 72).  Figure B represents samples purified with Qiagen MinElute® columns (N= 72). Purifications 
were done in triplicate.  The error bars represent 1 standard deviation from the mean.   
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Table 11.  Average allelic fold increase of purifications at 0.25ng and 0.125ng of 1:1 and 9:1 BD 
mixtures.  FI represents fold increase. Purifications were done in triplicate.  Average FI across alleles was 
taken from the 6 distinguishable loci.  
 
 
To further investigate the fold increase of a two fresh sample mixture, the fold 
increase of a mixture, AD mixture, was compared to the fold increase of its single source 
constituents, samples A and D.  The total fold increase of the mixture falls between the 
values of its individual contributors’ total fold increase (Figure 9).  
 
Purification
Mixture Ratio
Target Mass 0.125ng 0.25ng 0.125ng 0.25ng 0.125ng 0.25ng 0.125ng 0.25ng
Average FI across Alleles 4.76 3.49 4.18 3.92 5.52 5.44 5.05 4.15
Standard deviation 0.89 0.30 0.75 0.45 0.56 0.91 0.50 1.49
Average Allele FI/method
Standard deviation
4.09 5.04
0.60 0.86
Macherey-Nagel NucleoSpin® Qiagen MinElute®
1:1 9:1 1:1 9:1
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Figure 9.  Total fold increase of 7 discriminating loci from 1:1 AD mixture at 0.5ng target and single 
source samples A and D at 0.25ng targets.  Samples were purified with Macherey-Nagel NucleoSpin® 
and Qiagen MinElute® columns.  The value in the bottom left corner represents the mean total fold 
increase of each sample per purification column. Purifications were not replicated.  (N=7 for each sample). 
N= Number of data points included.  
 
These observations illustrate the use of post-amplification purification on single 
source and mixture samples.  The advantage of this technique is not diminished when it is 
applied to mixture samples as the mixture fold increase is not drastically different from 
single source samples.   
 
3.2.2 Two-person LTDNA mixture with two frozen saliva samples: EG & FG mixtures  
Samples E through G were extracted from frozen saliva samples.  Thus, mixture 
combinations with two frozen saliva samples included only samples E, F or G.  
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Contributor proportion and heterozygote balance along with allelic dropout of EG and FG 
mixtures were analyzed and compared before and after post-amplification purification 
with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns.  To investigate the 
effect of purification, fold increase was observed in both mixture samples. 
 
3.2.2.1 Contributor proportion and heterozygote balance 
Contributor proportions observed in the EG mixture do not coincide with 
expected ratios.  The mean proportion of contributor E observed was about 0.7 in both 
9:1 mixture targets, while the mean proportion of contributor G was about 0.2 in both 9:1 
mixture targets (Figure 10).  These values are not representative of a true 9:1 mixture.  
Congruently, the observed mean proportion of contributors in 1:1 mixtures at 0.125ng 
targets were not expected as the proportion of contributor E was about 0.4 while the 
proportion of contributor G was about 0.6.  Similar contributor proportions observed in 
1:1 EG mixture at 0.125ng were observed in the FG mixture (Figure 11).  However, the 
observed mean proportions of contributors were closer to expected 0.5 proportions in 1:1 
EG mixtures at 0.25ng.   
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Figure 10.  Mean proportion of contributor E and contributor G in 1:1 and 9:1 EG mixtures of 
0.25ng and 0.125 targets from 8 discriminating loci before and after post-amplification purification.  
Samples were purified with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns in triplicate 
(N= 96 each).  Non-purified samples were not replicated (N= 32).  The error bars represent 95% confidence 
interval from the mean. N= number of data points included. 
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Figure 11.  Mean proportion of contributor F and contributor G in 1:1 mixtures of 0.25ng targets 
from 6 discriminating loci before and after post-amplification purification.  Samples were purified 
with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns in triplicate (N= 18 each).  Non-
purified samples were not replicated (N= 6).  The error bars represent 95% confidence interval from the 
mean. N= number of data points included.  
 
 The inaccurate representation of 1:1 and 9:1 mixture samples is attributed to the 
components within each mixture.  EG and FG mixtures were setup in a similar manner as 
the BD mixture, but unlike the BD mixture the contributor proportions observed in the 
EG and FG mixtures are not representative of a true 1:1 or 9:1 mixture.  This discrepancy 
is likely due to sample storage as EG and FG mixtures contained frozen saliva samples 
while BD mixture contained fresh saliva samples. 
Even though the observed contributor proportions are not what was expected, the 
proportion of each contributor in the EG and FG mixtures were not affected by 
purification.  The contributor proportions were maintained after purification.    
43 
The heterozygote balance of non-purified EG mixture samples were similar to the 
heterozygote balance of purified samples (Figure 12).  Purification had no effect on 
improving the heterozygote balance.  The error bars of non-purified samples are larger 
than that of the purified samples due to the performance of a single run.  A similar trend 
was observed with FG mixture samples (Figure 13). 
 
 
 
Figure 12.  Mean heterozygote balance of each contributor in 1:1 and 9:1 EG mixtures of 0.25ng and 
0.125 targets from 8 discriminating loci before and after post-amplification purification.  Samples 
were purified with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns in triplicate (N= 96 
each).  Non-purified samples were not replicated (N= 32).  The error bars represent 95% confidence 
interval from the mean. N= number of data points included.  
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Figure 13.  Mean heterozygote balance of each contributor in 1:1 FG mixture at 0.25ng target from 6 
discriminating loci before and after post-amplification purification.  Samples were purified with 
Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns in triplicate (N= 18 each).  Non-purified 
samples were not replicated (N= 6).  The error bars represent 95% confidence interval from the mean. N= 
number of data points included.  
 
 
 
3.2.2.2 Allelic and locus dropout 
 The highest incidence of locus dropout was exhibited in 9:1 mixture ratio of non-
purified samples targeted at 0.125ng (Figure 14).  However, many of these lost alleles 
were recovered in purified samples.  
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Figure 14.  Allelic dropout of 1:1 and 9:1 EG mixture at 0.25ng and 0.125ng targets before and after 
post-amplification purification from 8 discriminating loci.  Samples were purified with Macherey-Nagel 
NucleoSpin® and Qiagen MinElute® columns. Non-purified samples were not replicated.   Purifications 
were done in triplicate.  Each data point represents the number of alleles dropped out per discriminating 
locus.  The blue triangles represent occurrence of locus dropout while the red circles indicate no locus 
dropout.  The value in the top right corner represents the sample size of each target mass per purification 
category.   
 
 
As expected, lower incidences of allelic dropout occurred in 0.25ng targets than 
0.125ng targets, in 1:1 mixture ratios than 9:1 mixture ratios, and in purified samples than 
non-purified samples.  Non-purified samples exhibited allelic dropout in all 8 
discriminating loci in 1:1 and 9:1 EG mixtures at 0.125ng (most of which led to locus 
dropout), while purified samples exhibited allelic dropout in 5 of the 8 discriminating loci 
in 1:1 and 9:1 mixtures at 0.125ng.  The 1:1 mixture at 0.125ng contained 0.0625ng of 
each contributor, while the 9:1 mixture at 0.125ng contained 0.1125ng of contributor E 
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and 0.0125ng of contributor G, refer to Table 9.  As expected, higher incidence of allelic 
dropout occurred in 9:1 mixture ratios than 1:1 mixture ratios.  However, this was only 
true for mixture samples targeted at 0.125ng.  In 0.25ng targets, higher incidences of 
allelic dropout occurred in 1:1 mixture ratios than 9:1 mixture ratios.   
According to table 9, 1:1 mixtures targeted at 0.25ng targets contain about 
0.125ng of each contributor while a 9:1 mixture targeted at 0.25ng contained about 
0.225ng of contributor E and about 0.025ng of contributor G.  The discrepant occurrence 
of allelic dropout between 0.125ng and 0.25ng targets can be explained by identifying the 
contributor that dropped out.   
 Contributor E exhibited higher incidences of allelic dropout in 1:1 mixture ratios 
than 9:1 mixture ratios and in 0.25ng targets than 0.125ng targets, while contributor G 
exhibited higher incidences of allelic dropout in 9:1 mixture ratios than 1:1 mixture ratios 
and in 0.125ng than 0.25ng targets (Figure 15).  Prior to purification, the highest 
incidence of allelic and locus dropout of contributor E occurred in the 1:1 mixture at 
0.125ng; alleles dropped out in 7 out of the 8 discriminating loci which led to the dropout 
of 5 loci (Table 12).  The occurrence of allelic dropout of contributor E in the 1:1 mixture 
samples is justified given the degradation of sample E since no alleles dropped out in 9:1 
mixture samples.  At the 0.125ng mixture target 0.0625ng of contributor E was targeted 
in a 1:1 mixture, but in a 9:1 mixture 0.1125ng was targeted.  Prior to purification, the 
highest incidence of allelic dropout for contributor G, resulting in complete dropout at all 
discriminating loci, occurred in the 9:1 mixtures at 0.25ng and 0.125ng targets.  This 
observation is expected since the target mass of contributor G reduced in the 9:1 
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mixtures.  In 0.25ng of 9:1 mixture, 0.025ng of contributor G was targeted, while 
0.0125ng of contributor G was targeted in 0.125ng of 9:1 mixture. 
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Figure 15.  Allelic dropout of EG mixture of each contributor before and after post-amplification 
purification from 8 discriminating loci.   Figure A illustrates relationship of allelic dropout vs. target 
mass. Figure B illustrates relationship between allelic dropout vs. mixture ratio.  Samples were purified 
with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns in triplicate. Non-purified samples 
were not replicated.  Each data point represents the number of alleles dropped out per discriminating loci.  
The blue triangles represent occurrence of locus dropout while the red circles indicate no locus dropout.  
The value in the bottom right corner represents the sample size of each contributor category that exhibited 
allelic dropout. 
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Table 12.  Allelic and locus dropout of 1:1 and 9:1 EG mixtures at 0.25ng and 0.125ng targets before 
and after purification from 8 discriminating loci.  Samples were purified with Macherey-Nagel 
NucleoSpin® and Qiagen MinElute® columns.  Non-purified samples were not replicated.  Purifications 
were done in triplicate.  
 
 
 
Purification of the EG mixture reduced incidence of allelic and locus dropout of 
each contributor.  After purification, allelic dropout of 0.0625ng of contributor E in 1:1 
mixture at 0.125ng reduced from occurring in 7 out of the 8 loci to 1 out of 8 loci in 
samples purified with NucleoSpin® and MinElute® columns.  Similarly, locus dropout 
of 0.0625ng of contributor E in 1:1 mixtures at 0.125ng reduced from occurring in 5 out 
of 8 loci before purification to 1 out of the 8 loci after purification with NucleoSpin® 
columns, but samples purified with MinElute® columns exhibited no locus dropout.  
After purification, allelic dropout of 0.025ng of contributor G in 9:1 mixtures at 0.25ng 
and 0.0125ng of contributor G in 9:1 mixtures at 0.125ng reduced from occurring in all 
discriminating loci for both targets to no allelic dropout in all purified 0.25ng samples, 5 
out of 8 loci in 0.125ng samples purified with NucleoSpin® columns and 4 out of 8 loci 
in 0.125ng samples purified with MinElute® columns.  Similarly, locus dropout of 
contributor G in 9:1 mixtures at 0.25ng and 0.125ng targets reduced from occurring in all 
discriminating loci before purification to 2 out of the 8 loci in purified 0.125ng samples, 
Purification
Mixture 
Ratio
Target 
Mass
0.125ng 0.25ng 0.125ng 0.25ng 0.125ng 0.25ng 0.125ng 0.25ng 0.125ng 0.25ng 0.125ng 0.25ng
Both 0 0 0 0 6 2 4 3 0 0 0 0
E 3 3 0 2 1 2 0 0 3 3 0 1
G 0 0 14 0 1 1 4 5 0 0 12 0
Both 0 0 0 0 4 1 4 0 0 0 0 0
E 2 0 0 0 1 1 0 0 0 0 0 0
G 0 0 6 0 1 1 4 8 0 0 5 0
Macherey-Nagel Nucleospin No Qiagen Minelute
Contributor exhibited allelic dropout within  discriminating loci
Contributor exhibited locus droput
1:1 9:1 1:1 9:1 1:1 9:1
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but no locus dropout occurred in purified 0.25ng samples.  The alleles of contributor G 
were recovered in purified samples.   
Non-purified samples exhibited allelic dropout (and locus dropout in extreme 
cases) of both contributors, but these alleles were recovered after purification.  The 
recovery of alleles improved the sample quality from detecting a partial profile to a full 
profile of contributor E, as observed in 0.125ng of 9:1 mixture.  Since contributor E was 
degraded the recovery of alleles illustrates the use of purification with degraded samples.  
Similarly, the sample quality improved with purified samples since enough alleles from 
contributor G were detected to generate a partial profile, as observed in 0.25ng of 9:1 
mixture, or even a full profile, as observed in 0.125ng of 9:1 mixture (Table 12).   
The recovery of alleles in purified samples was also evident in the FG mixture.  
Dropout was only observed in non-purified 1:1 FG mixtures at 0.25ng, but these alleles 
were recovered after purification.  Purified samples can facilitate the interpretation of 
LTDNA mixtures by providing substantial genetic information to include or exclude an 
individual from the inferred profiles of contributor 1 or contributor 2.    
 
3.2.2.3 Allelic Fold increase 
Allelic fold increase differed between purification columns.  The fold increase of 
samples purified with MinElute® columns was higher than samples purified with 
NucleoSpin® columns (Figure 16).  The mean allelic fold increase of MinElute® 
columns was 4.77 ± 0.94, while the mean allelic fold increase of NucleoSpin® columns 
was 4.33 ± 0.88  (Table 13). However, the mean allelic fold increase of NucleoSpin® 
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samples was more precise than MinElute® samples overall as indicated by the standard 
deviation in Table 13.  
 
Figure 16.  Mean allelic fold increase of 1:1 and 9:1 EG mixtures at 0.25ng and 0.125 targets from 8 
discriminating loci.  Figure A represents samples purified with Macherey-Nagel NucleoSpin® columns 
(N= 96).  Figure B represents samples purified with Qiagen MinElute® columns (N= 96). N= number of 
data points included.  Purifications were done in triplicate.  The error bars represent 1 standard deviation 
from the mean.   
52 
Table 13.  Average allelic fold increase of purifications at 0.25ng and 0.125ng of 1:1 and 9:1 EG 
mixtures.  FI indicates fold increase.  Purifications were done in triplicate. Average FI across alleles was 
taken from the 8 distinguishable loci. 
 
  
The trend observed in EG mixture samples was reflective in the FG mixture.  
Samples purified with MinElute® columns had a higher fold increase than samples 
purified with NucleoSpin® columns (Figure 17).  The mean fold increase across the 
alleles of discriminating loci for samples purified with NucleoSpin® columns was 4.55 ± 
0.95, while the mean fold increase across the alleles of discriminating loci for samples 
purified with MinElute® columns was 5.07 ± 0.45.  Unlike the EG mixture, the FG 
mixture illustrates precision with the MinElute® column rather than the NucleoSpin® 
column.   
 
 
Purification
Mixture Ratio
Target Mass 0.125ng 0.25ng 0.125ng 0.25ng 0.125ng 0.25ng 0.125ng 0.25ng
Average FI across Alleles 4.47 4.91 4.15 3.81 5.07 5.34 4.26 4.41
Standard deviation 1.18 0.58 1.11 0.65 1.15 0.69 1.32 0.63
Average Allele FI/method
Standard deviation
4.33
0.88
4.77
0.94
Macherey-Nagel NucleoSpin® Qiagen MinElute®
1:1 9:1 1:1 9:1
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Figure 17.  Mean allelic fold increase of 1:1 FG mixture at 0.25ng target from 6 discriminating loci.  
Samples were purified with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns in triplicate 
(N= 18 each).  N= number of data points included. The error bars represent 1 standard deviation from the 
mean.   
 
 
3.2.3 Two-person LTDNA mixture with one frozen saliva sample and one fresh saliva 
sample: GD & FC mixtures 
Samples A through D were extracted from fresh saliva samples, while samples E 
through G were extracted from frozen saliva samples.  The mixture combination that 
provided the highest number of discriminating loci was GD.  Thus, this mixture was 
utilized to further characterize the peak heights, heterozygote balance of each contributor 
and fold increase before and after post-amplification purification with Macherey-Nagel 
NucleoSpin® and Qiagen MinElute® columns.  Unlike other mixtures, the non-purified 
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samples were injected for 10 seconds instead of 5 seconds.  To ensure the trends observed 
in the GD mixture were reproducible the contributor proportion, contributor heterozygote 
balance, dropout and fold increase was observed in the FC mixture. 
 
3.2.3.1 Contributor proportion and heterozygote balance 
 The observed contributor proportions of the GD and FC mixtures are not 
consistent with expected values.  The observed mean proportion of contributor G was 
about 0.1, while the observed mean proportion of contributor D was about 0.9 in 1:1 
mixtures at all target masses (Figure 18).  These values indicate that the mixtures that 
were setup as 1:1 were in fact 1:9, with more contribution coming from the second 
contributor: contributor D.  This trend was also seen in the FC mixture as the observed 
mean proportion of contributor F was about 0.1 and the observed mean proportion of 
contributor C was about 0.9 in 1:1 mixtures at all target masses (Figure 19).  The 
observed mean proportion of each contributor in 4:1 and 9:1 GD and FC mixtures did not 
represent true 4:1 and 9:1 mixtures.  The observed contributor proportions in the 4:1 FC 
mixture appeared to be more like a 1:1 mixture as the proportion of each contributor was 
about 0.5; meanwhile the observed contributor proportions in the 9:1 mixture appeared to 
be 3:2 as the observed mean proportion of contributor F was about 0.6 and the observed 
mean proportion of contributor C was about 0.4 in all target masses.  The GD mixture 
had a similar trend, but the 4:1 mixture appeared to be more like a 2:3 mixture (with a 
higher proportion of contributor D than contributor G) while the 9:1 mixture appeared to 
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be more like a 1:1 mixture.  The difference in contributor proportion in 4:1 and 9:1 
mixtures of GD and FC mixture samples is likely due to the components of each mixture. 
   
 
 
Figure 18.  Mean proportion of contributor G and contributor D in 1:1, 4:1 and 9:1 GD mixtures of 
0.5ng, 0.25ng and 0.125 targets from 10 discriminating loci before and after post-amplification 
purification.  Samples were purified with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns 
in triplicate (N= 260 each).  Non-purified samples were not replicated (N= 90).  N= number of data points 
included.  The error bars represent 95% confidence interval from the mean.  
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Figure 19.  Mean proportion of contributor F and contributor C in 1:1, 4:1 and 9:1 FC mixtures of 
0.5ng, 0.25ng and 0.125 targets from 6 discriminating loci before and after post-amplification 
purification.  Samples were purified with Macherey-Nagel NucleoSpin® (N= 102) and Qiagen MinElute® 
(N= 108) columns in duplicate.  Non-purified samples were not replicated (N= 54).  N= number of data 
points included.  The error bars represent 95% confidence interval from the mean.  
 
As indicated in the characterization of single source samples, frozen samples had 
lower peak heights and higher ranges in heterozygote balance than fresh saliva samples.  
However, the degree which these characteristics are true for each sample is variable as 
the mean peak height of sample G is different than the mean peak height of sample F; the 
same is true for samples D and C (Figure 2).  The proportion of each contributor is likely 
affected by sample storage and the nature of the sample.   
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Heterozygote balance was not affected by purification.  The heterozygote balance 
of each contributor was maintained after purification with either the NucleoSpin® or 
MinElute® column (Figures 20 & 21).  The error bars of the purified samples are smaller 
than the non-purified samples due to replicate runs.   
 
 
 
Figure 20.  Mean heterozygote balance of each contributor in 1:1, 4:1 and 9:1 GD mixtures of 0.5ng, 
0.25ng and 0.125 targets from 10 discriminating loci before and after post-amplification purification.   
Samples were purified with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns in triplicate 
(N= 260 each).  Non-purified samples were not replicated (N= 90).  N= number of data points included.  
The error bars represent 95% confidence interval from the mean.   
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Figure 21.  Mean heterozygote balance of each contributor in 1:1, 4:1 and 9:1 FC mixtures of 0.5ng, 
0.25ng and 0.125 targets from 6 discriminating loci before and after post-amplification purification.   
Samples were purified with Macherey-Nagel NucleoSpin® (N= 102) and Qiagen MinElute® (N= 108) 
columns in duplicate.  Non-purified samples were not replicated (N= 54).  N= number of data points 
included.  The error bars represent 95% confidence interval from the mean.  
 
3.2.3.2 Allelic and locus dropout 
 As expected, dropout was prevalent in lower target masses and higher mixture 
ratios.  Dropout was observed in 0.125ng at all mixture ratios for the GD and FC 
mixtures.  The locus dropouts observed in non-purified GD mixtures were fully 
recovered in purified samples (Figure 22).  The purified samples in the FC mixture were 
not able to recover all of the alleles lost before purification, but it reduced the occurrence 
of allelic dropout (Figure 23). 
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Figure 22.  Allelic dropout of 1:1, 4:1 and 9:1 GD mixtures at 0.5ng, 0.25ng and 0.125ng targets 
before and after post-amplification purification from 10 discriminating loci.  Samples were purified 
with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns. Non-purified samples were not 
replicated.   Purifications were done in triplicate.  Each data point represents the number of alleles dropped 
out per discriminating locus.  The blue triangles represent occurrence of locus dropout while the red circles 
indicate no locus dropout.   
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Figure 23.  Allelic dropout of 1:1, 4:1 and 9:1 FC mixture at 0.5, 0.25ng and 0.125ng targets before 
and after post-amplification purification from 6 discriminating loci.  Samples were purified with 
Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns. Non-purified samples were not replicated.   
Purifications were done in duplicate.  Each data point represents the number of alleles dropped out per 
discriminating locus.  The blue triangles represent occurrence of locus dropout while the red circles 
indicate no locus dropout.   
 
3.2.3.3 Allelic fold increase 
Allelic fold increase in RFU was equivalent across the loci in all GD mixture 
samples except 9:1 mixture ratio of 0.125ng target samples of both purification columns 
(Figure 24).  The variability in fold increase across the 10 loci may be due to the storage 
condition and limited amount of DNA in the sample.  The allelic fold increase in FC 
mixture also exhibited variability in 0.125ng of 9:1 mixture ratio, but unlike the GD 
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mixture the fold increase was higher than other samples (Figure 25).  Further studies 
must be conducted to characterize difference in sample storage conditions. 
 
 
Figure 24.  Mean allelic fold increase of 1:1, 4:1 and 9:1 GD mixtures at 0.5ng, 0.25ng and 0.125ng 
targets from 10 discriminating loci.  Figure A represents samples purified with Macherey-Nagel 
NucleoSpin® columns (N= 260).  Figure B represents samples purified with Qiagen MinElute® columns 
(N= 260). N= number of data points included.  Purifications were done in triplicate.  The error bars 
represent 1 standard deviation from the mean.  The allelic fold increase of allele 2 from the NucleoSpin®  
purified 1:1 mixture targeted at 0.125ng at locus D2S1338 was deleted. Non-purified samples were injected 
for 10 seconds while purified samples were injected for 5 seconds. 
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Figure 25.  Mean allelic fold increase of 1:1, 4:1 and 9:1 FC mixtures at 0.5ng, 0.25ng and 0.125ng 
targets from 6 discriminating loci.  Figure A represents samples purified with Macherey-Nagel 
NucleoSpin® columns (N= 54).  Figure B represents samples purified with Qiagen MinElute® columns 
(N= 54).  N= number of data points included.  Purifications were done in duplicate, but only purified 
samples with 10μl of product were included in the figure.  The error bars represent 1 standard deviation 
from the mean.   
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Allelic fold increase differed between purification columns.  The fold increase of 
samples purified with MinElute® columns was higher than samples purified with 
NucleoSpin® columns in both GD and FC mixtures.  The mean allelic fold increase of 
GD samples was slightly higher in samples purified with Qiagen MinElute® columns, 
2.74 ± 0.65, than samples purified with Macherey-Nagel NucleoSpin® columns, 2.55 ± 
0.42 (Table 14).  However, the allelic fold increase of NucleoSpin® purified samples was 
more precise than MinElute® purified samples as indicated by the standard deviation. 
 
 
Table 14. Average allelic fold increase of 0.5ng, 0.25ng and 0.125ng of 1:1, 4:1 and 9:1 GD mixtures.  
FI refers to fold increase.  Purifications were done in triplicate. Non-purified samples were injected at 10 
seconds while purified samples were injected at 5 seconds.  Average FI across alleles was taken from the 
10 distinguishable loci. 
 
 
A similar trend was observed in FC mixture samples as the mean allelic fold 
increase of MinElute® columns was 5.71 ± 0.48, while the mean allelic fold increase of 
NucleoSpin® columns was 5.59 ± 0.41 (Table 15).  FC mixture samples purified with 
MinElute® columns had a higher fold increase than samples purified with NucleoSpin® 
columns, but there was a higher precision in NucleoSpin® columns. 
Purification
Mixture Ratio
Target Mass 0.125ng 0.25ng 0.5ng 0.125ng 0.25ng 0.5ng 0.125ng 0.25ng 0.5ng
Average FI across alleles 2.80 2.84 2.64 3.42 2.33 2.74 0.84 2.77 2.60
Standard deviation 0.40 0.34 0.27 0.84 0.31 0.30 0.54 0.40 0.39
Average FI per method
Standard deviation
Purification
Mixture Ratio
Target Mass 0.125ng 0.25ng 0.5ng 0.125ng 0.25ng 0.5ng 0.125ng 0.25ng 0.5ng
Average FI across alleles 2.36 3.18 2.43 4.41 2.90 2.96 0.71 2.96 2.70
Standard deviation 0.27 0.59 0.19 1.45 0.15 1.02 0.49 0.87 0.83
Average FI per method
Standard deviation
2.55
0.42
2.74
0.65
Macherey-Nagel NucleoSpin®
Qiagen MinElute®
1:1 4:1 9:1
1:1 4:1 9:1
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Table 15. Average allelic fold increase of 0.5ng, 0.25ng, 0.125ng of 1:1, 4:1, and 9:1 FC mixtures.  FI 
refers to fold increase.  Purifications were done in duplicate.  Average FI across alleles was taken from the 
6 distinguishable loci. 
 
 
3.2.3.4 Background noise of CE 
 To determine if post-amplification purified samples elevated the peak heights of 
background noise the peaks below the analytical threshold, which was set to 30RFU, 
were examined.  In addition to elevated allele peaks heights, a slight increase in 
background noise was also observed with purified samples (Figure 26).  These peaks 
included stutter and elevated noise from the instrument.  Stutter peaks in the purified 
samples exceeded the analytical thresholds in some samples, but the elevated noise from 
the instrument did not.  The stutter peaks observed were within normal range.  
  
 
Purification
Mixture Ratio
Target Mass 0.125ng 0.25ng 0.5ng 0.125ng 0.25ng 0.5ng 0.125ng 0.25ng 0.5ng
Average FI across alleles 4.68 5.28 4.91 4.07 4.18 5.89 7.60 5.73 7.95
Standard deviation 0.57 0.11 0.54 0.41 0.12 0.24 0.85 0.52 0.30
Average FI per method
Standard deviation
Purification
Mixture Ratio
Target Mass 0.125ng 0.25ng 0.5ng 0.125ng 0.25ng 0.5ng 0.125ng 0.25ng 0.5ng
Average FI across alleles 4.68 5.36 5.46 4.07 6.55 5.54 9.08 3.80 6.85
Standard deviation 0.57 0.43 0.22 0.41 0.44 0.34 1.10 0.30 0.50
Average FI per method
Standard deviation
1:1 4:1 9:1
Qiagen MinElute®
5.71
0.48
1:1 4:1 9:1
Macherey-Nagel NucleoSpin®
5.59
0.41
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Figure 26.  Electropherogram of 0.125ng of 4:1 GD mixture before and after purification using the 
blue dye loci.  Figure 26A represents sample purified with Macherey-Nagel NucleoSpin® columns.  Figure 
26B represents non-purified sample.  Figure 26C represents sample purified with Qiagen MinElute® 
columns.  All samples were injected into CE for 5 seconds. The y-axis of Figures 26A through 26C are at 
30RFU.  
 
 
3.3 Comparison of post-amplification purification silica columns 
 Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns maintained the 
heterozygote balance of single source and mixture samples, as seen in figures 3, 6, 12, 13, 
20 and 21, and the contributor proportion of mixture samples, as seen in figures 5, 10, 11, 
18 and 19.  Both columns show elevation in peak height of samples, but as indicated in 
0.25ng single source samples the peak height of samples purified with Qiagen 
MinElute® columns were higher than samples purified with Macherey-Nagel 
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NucleoSpin® columns (Figure 2).  The higher peak heights in samples purified with 
MinElute® columns explain the reduced occurrence of dropout in the discriminating 
alleles of a degraded sample, sample E within the EG mixture sample, as seen in figure 
15.  However, both columns equally recovered alleles in single source and mixture 
samples, as seen in figures 4 and 7.   
 Both silica columns increased the peak heights of alleles after purification, but the 
mean fold increase of samples purified with Qiagen MinElute® columns was higher than 
the mean fold increase of samples purified with Macherey-Nagel NucleoSpin® columns 
(Figure 27).  When the mean total fold increase of all mixtures was calculated the overall 
mean fold increase of samples purified with MinElute® columns was 4.64 ± 1.18, while 
the mean fold increase of samples purified with NucleoSpin® columns was 3.98 ± 1.01. 
The fold increase of samples purified with Macherey-Nagel NucleoSpin® 
columns was more precise than the fold increase of samples purified with Qiagen 
MinElute® columns, as indicated by the range of data (Figure 27).  This was true for all 
mixtures analyzed except for the FG mixture.  The FG mixture exhibited a higher fold 
increase and better precision in samples purified with MinElute® columns.  Further tests 
must be conducted to determine the exact cause of difference in trend between FG and 
other mixture samples.  
   
  
67 
 
Figure 27.  Average total fold increase of all mixture samples analyzed of 1:1 mixture at 0.25ng.  
Samples were purified with Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns.  All 
samples were purified in triplicate except the FC mixture which was done in duplicate.  The sample size of 
each mixture was dependent on the number of distinguishable loci between contributors. (NBD= 18 each; 
NEG= 24 each; NFC= 6 each; NFG= 18 each; NGD= 30 each) N= number of data points included for each 
purification column. 
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Table 16.  Average total fold increase of two-person mixture samples purified with  Macherey-Nagel 
NucleoSpin® and Qiagen MinElute® columns.  FI represents fold increase.  
 
 
To illustrate the performance of each silica column directly, replicate purifications 
of each column and the primer front size of each silica column were observed. 
 
3.3.1 Fold increase and replicate purifications 
The allelic fold increase of GD mixtures purified with Qiagen MinElute® 
columns was higher than GD mixtures purified with Macherey-Nagel NucleoSpin® 
columns in all samples except 0.125ng of 1:1 mixture, 0.5ng of 1:1 mixture and 0.125ng 
of 9:1 mixture (Table 14).  However, the overall mean allelic fold increase for samples 
purified with MinElute® columns was 2.75 ± 0.28 and for samples purified with 
NucleoSpin® columns was 2.55 ± 0.27. 
The allelic fold increase of each allele was similar in all repeat purifications of 
both silica columns, except for mixtures at 0.25ng and 0.125ng targets (Figure 28).  This 
variation may be due to the low mass since it is more susceptible to pipetting error.  In 
fact, the GD mixture showed indications of degradation in the red dye with a slope in 
Fresh, Fresh
Mixture BD EG FG FC GD
Average Total FI 3.52 4.89 4.56 5.28 2.91
Standard Deviation 0.29 0.46 0.94 0.11 0.26
Fresh, Fresh
Mixture BD EG FG FC GD
Average Total FI 5.48 5.33 5.08 5.36 3.19
Standard Deviation 0.9 0.63 0.45 0.43 0.58
Frozen, Frozen Frozen, Fresh
Macherey-Nagel NucleoSpin® 
 Qiagen MinElute®
Frozen, Frozen Frozen, Fresh
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peak heights.  This trend was observed in all GD mixture samples.  Thus, the lower mass 
and degradation of the sample limit the level of enhanced peak heights with purification.   
 
 
 
Figure 28.  Mean allelic fold increase of purification repeats in 0.5ng, 0.25ng GD mixtures from 10 
discriminating loci.  Samples were purified in triplicate with Macherey-Nagel NucleoSpin® and Qiagen 
MinElute® columns (N=260/column).  The error bars represent 1 standard deviation from the mean.  
Mixture ratio disregarded due to components of mixture: fresh and frozen samples.  
 
 
 
3.3.2 Primer front  
 
Samples were purified after amplification to ensure other components of PCR: 
primers were excluded or at the very least reduced to encourage the injection of DNA.  
To determine if primers were reduced, the primer front of a purified sample was 
compared to the primer front of a non-purified sample.  The primer front is the region of 
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the electropherogram that is unresolved; this region is known to contain fluorescent 
signals from components other than amplified DNA.   
The primer front of a sample was reduced after it was purified, but the degree of 
this reduction differed (Figure 29).  Samples purified with Macherey-Nagel NucleoSpin® 
columns exhibited a smaller primer front and a more resolved baseline than samples 
purified with Qiagen MinElute® columns.  The primer front size of replicate samples 
purified with Macherey-Nagel NucleoSpin® columns were more consistent than replicate 
samples purified with Qiagen MinElute® columns.   
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Figure 29.  Electropherogram raw data of 9:1 GD mixture at 0.125ng before and after post-
amplification purification. Figures A1 and A2 represent raw data from replicate purifications with 
Macherey-Nagel NucleoSpin® columns. Figure B represents raw data from sample before post-
amplification purification (non- purified sample). Figures C1 and C2 represent raw data from replicate 
purifications with Qiagen MinElute® columns.  The y-axis measures peak height in relative fluorescence 
units (RFU); maximum y value in all figures is 10,000RFU.   
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4. DISCUSSION 
Standard PCR has revolutionized the analysis of nucleic acids by expanding the 
application of DNA profiling from biological fluids to biological stains on inanimate 
objects.  The bounds of this process were extended to LTDNA samples by detecting 
single cells that can be found on touched items and detecting secondary transfer between 
individuals [47]–[49].  However, reliable detection of alleles in these types of samples is 
challenging due to low peak heights and stochastic effects: dropout, stutter, and 
heterozygote imbalance.  Enhancement techniques, like post-amplification purification 
with silica columns, improve the detection sensitivity of LTDNA profiles by elevating 
peak heights. 
Increased peak heights of purified samples did not affect contributor proportion or 
heterozygote balance of either contributor within a two-person mixture.  These findings 
corroborate with a study of post-amplification purification conducted on LTDNA single 
source samples.  The heterozygote balance of purified and  non-purified samples were 
similar, but variation in heterozygote balances were due to decrease in template mass 
[40].  Given the findings in this study along with past work on single source samples, it is 
not appropriate to compare heterozygote balances of non-purified samples at 1ng to 
purified samples ranging from 78pg to 5pg as conducted by Smith & Ballantyne [29].   
The sensitivity of post-amplification purification with silica columns was not 
conducted in this study, but literature has shown full profiles were generated from 79pg 
and 62.5pg of template purified with Qiagen MinElute® columns [29], [40].  Combining 
this method with other enhancement techniques can elevate detection of even lower 
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template masses, 20pg and 10pg samples, by recovering 8% of peaks not seen in purified 
samples [29], [50].  The coupling of increased product volume into a  CE with post-
amplification purification by silica columns have higher sample profile peaks than 
samples that are not purified, but even higher peak heights are exhibited in samples with 
a combination of increased product, post amplification purification and elevated injection 
times [33].  However, other enhancement techniques can cause issues:  reduced migration 
of alleles by 1.4-2bp (when product volume increased) which led to miss-alignment of 
alleles with the ladder making interpretation of profiles difficult [29].  Combining 
enhancement techniques must be done carefully as the performance of one method alone 
may not be comparable to its performance in combination with other methods [51].  
Post-amplification purification is agreeable with other enhancement techniques 
that do not interfere with its ability to reduce primers.  The reduction in primer peaks by 
post-amplification purification with silica columns is agreeable with other studies.  Smith 
& Ballantyne observed reduced primer fronts in samples purified with Qiagen 
MinElute® columns compared to non-purified samples [29].  In a colleague’s study, the 
primer front of samples purified with MinElute® and NucleoSpin® columns were 
reduced in single source samples as low as 0.0625ng [40].  Similar to this study, the 
effect MinElute® and NucleoSpin® columns have on the primer front and peak heights 
differ as MinElute® purified samples have higher peak heights while NucleoSpin® 
purified samples have smaller primer fronts [40].  The tradeoff between peak height and 
primer front is not drastic as both silica columns exhibited a 3.2 fold increase which was 
not affected by template mass [40].  
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This study briefly observed the effect of sample storage condition prior to 
extraction and its effect on peak height and heterozygote balance.  Extracts from frozen 
samples behaved differently than extracts from fresh samples.  Understanding the 
mechanism of this difference would refine forensic practices as many samples are kept in 
freezers to preserve sample integrity for long time periods.  A study conducted by Ng et. 
al. illustrated the effect storage condition had on the amount of DNA extracted; whole 
saliva samples stored for a week or a month had lower mean PCR product band volumes 
than samples extracted on the same day of collection, but subjecting whole saliva samples 
to a wash or centrifugation prior to storage yielded closer PCR product band volumes to 
samples extracted on the same day of collection[52].  It would be interesting to determine 
if the peak heights, heterozygote balance and contributor proportions of a mixture sample 
processed on the same day is affected by the time which a sample is stored storage since 
the mixtures analyzed in this study were processed within a few weeks of each other. 
Post-amplification purification is a useful tool for forensic analysis of LTDNA 
single source and mixture samples due to the preservation of contributor proportion and 
heterozygote balance and elevated peak heights.  This effect was observed in all samples 
regardless of sample storage condition, making it applicable for forensic evidence.  
Forensic evidence conditions and types vary so the degree of elevated peak heights varies 
with each sample condition/type:  mean peak heights of trace saliva and blood are higher 
than biological samples obtained in worn gloves, grabbed clothing, trace semen, hair and 
touched items [33].  Comparable to the post-amplification purification of saliva, post-
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amplification purification of bloodstains provided a mean fold increase of  3.8 +/- 0.5 
[53].   
Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns increase peak 
heights, but do not eliminate the stochastic effects of LTDNA.  Stochastic effects of 
LTDNA samples are a concern since they complicate profile interpretation; this is 
especially true for mixture samples.  Stutter and allelic drop-in were not analyzed in this 
study, but LTDNA had a high range in stutter ratio [19].  More stutter was observed in 
samples after purification than before [33].  However, these results are not consistent 
with another study that found the stutter percent to be unaffected by purification [40].  
This discrepancy in results is likely attributed to the stochastic nature of stutter, which 
was proven in the loss of its occurrence upon re-amplification [29].   
This study did not analyze drop-in or the occurrence of extreme dropout. Future 
experiments can compare the effect of post-amplification purification on these variables.  
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5. CONCLUSIONS 
According to manufacturers, Macherey-Nagel NucleoSpin® columns remove 
nucleotides, primers, enzymes, mineral oil, PCR additives, detergents, dyes and unbound 
labels; meanwhile Qiagen MinElute® columns remove enzymes, salts and oligomers 
[45], [46].  The ability to remove extraneous components of PCR led to elevated peak 
heights of both contributors in two person LTDNA mixtures.  Due to elevated peak 
heights, occurrence of allelic and locus dropout reduced after purification with Macherey-
Nagel NucleoSpin® and Qiagen MinElute® columns.  Elevated peak heights did not alter 
the heterozygote balance of either contributor and did not alter the contributor 
proportions within the mixture.  Both silica columns enhanced recovery in alleles 
compared to non-purified samples.  Samples purified with Qiagen MinElute® columns 
generated slightly higher peak heights, higher fold increase by a factor of 1, and less 
occurrence of locus dropout than samples purified with Macherey-Nagel NucleoSpin® 
columns in most comparisons.  However, samples purified with Macherey-Nagel 
NucleoSpin® columns were more consistent in replicate purifications in most 
comparisons and had smaller primer fronts in all comparisons than samples purified with 
Qiagen MinElute® columns.  Due to its accuracy, Macherey-Nagel NucleoSpin® 
columns are more appropriate for mixture samples, while Qiagen MinElute® columns 
would be better for single source samples due to its elevated fold increase.  However, 
stochastic threshold must be re-evaluated prior to implementation of either of the 
purification columns. 
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6. Future steps 
 Applying Macherey-Nagel NucleoSpin® and Qiagen MinElute® columns to 
mock casework samples would be useful to determine if inferred genotypes of a two-
person LTDNA mixture of each contributor can be reliably determined, particularly in a 
1:9 ratio and without evidence of a third contributor.  While increasing the number of 
alleles observed in mixtures with more than two people, it is unlikely that there would be 
a sufficient increase in information to allow contributor genotypes to be determined.   
Before analyzing mock casework samples, it would be helpful to determine the 
sensitivity of each purification column by using further dilution studies combined with 
single tube extraction procedures to reduce the loss of DNA at extraction and increase 
signal following amplification and electrophoresis.   
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APPENDIX A:  Quantitative Data 
Table A. QPCR data of seven single source samples. Samples were quantified in duplicate and 
concentration was averaged.  Duplicate Ct values were from the duplicate quantifications.  If the Ct value 
of IPC fell out of the 20-30 range PCR inhibition was considered.  
Sample Average quantification 
value (ng/ul) 
Ct values of IPC from 
duplicate quantifications 
A 33.18 28.24; 27.94 
B 8.29 25.31; 27.20 
C 5.62 27.16; 27.19 
D 8.79 27.02; 27.08 
E 2.20 27.03; 27.21 
F 1.76 27.20; 27.11 
G 1.07 27.49; 27.23 
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